SIU Scientific Programme 2019


Wednesday, October 16

Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.

0800-1800

PRECON-01: 9th Eurasian Uro-Oncology Congress  

Room: Omikron
Chair: M. Ihsan Karaman, Türkiye
0800-0940    

Oral presentations

Moderator: İlhan Geçit, Türkiye
   

Effect of Autologous Fibrin Glue on Lymphatic Drainage and Lymphocele Formation in Extended Bilateral Pelvic Lymphadenectomy in Robot-Assisted Radical Prostatectomy

Presenter: Fatih Atug, Turkey
   

Predictive Parameters on the Effect of Ofloxacin Treatment on the Reduction of PSA in Patients with elevated PSA Level

Presenter: Yavuz Onue Danacıoğlu, Turkey
   

Relationship Between Bone Alkaline Phosphatase Level and Bone Metastases in Urological Cancers

Presenter: Huseyin Aytac Ates, Turkey
   

Perineoscopic Bladder Neck Reconstruction

Presenter: Yavuz Onue Danacıoğlu, Turkey
   

The Outcomes of Perineoscopic Radical Prostatectomy

Presenter: Yavuz Onue Danacıoğlu, Turkey
   

Outcomes of Robotic Radical Prostatectomy in Elderly Patients Older Than 70 Years Old

Presenter: Erdem Koç, Turkey
   

Can patient characteristics and response time to previous hormonal treatments be predictive of deciding post-docetaxel hormonal therapy or secondary chemotherapy in patients with CRPC?

Presenter: Gökşen Inanç Imamoğlu, Turkey
   

Is Neutrophil / Lymphocyte Ratio Important in Estimating Gleason Groups after Prostate Biopsy?

Presenter: Ramazan Topaktaş, Turkey
   

MRI-guided Fusion Prostate Biopsy Results in Patients with Previous Negative Biopsy: Single Center Experience

Presenter: Gökhan Sönmez, Turkey
   

MRI-guided Fusion Prostate Biopsy Results in Biopsy Naïve Patients: Single Center Experience

Presenter: Gökhan Sönmez, Turkey
   

The Effect of D’amico Risk Classification on Operative Time in Robot-Assisted Laparoscopic Radical Prostatectomy

Presenter: Ekrem Güner, Turkey
   

Comparison of All Body Bone Scintigraphy and Ga-68 PSMA PET / CT Findings in Screening of Skeletal System Metastases in Patients with Prostate Cancer

Presenter: Mehmet Esat Kösem, Turkey
   

Active surveillance in low-risk prostate cancer: 96-month follow-up results

Presenter: Yavuz Onue Danacıoğlu, Turkey
   

Impact of Eliminating The Lateral Trocars During Extraperitoneal Radical Prostatectomy; The Initial Series of Pilot Study

   

Predictive factors on survival with AR axis-targeted drugs for mCRPC

Presenter: Özgecan Dülgar, Turkey
   

Laparoscopic Radical Prostatectomy; 15 Years Experience

Presenter: Yavuz Mert Aydin, Turkey
0940-1000    

Opening Remarks

Selami Albayrak, Türkiye
Alivizatos Gerasimos, Greece
M. Ihsan Karaman, Türkiye
1000-1130    

Session 1- Mechanism and Biology – Diagnosis and Treatment of Urothelial Cancer

Moderators
Alivizatos Gerasimos, Greece
Oner Sanli, Turkey
1000-1015    

Molecular Pathways in Urothelial Cancer

Dilek Telci, Turkey
1015-1030    

Genomic Philosophy and Biomarkers for Treatment Selection in Urothelial Cancer

Peter Black, Canada
1030-1040    

Discussion

1040-1130    

BCG Refractory Diseases

1040-1050    

Mechanism of Resistance to BCG

Oktay Akça, Turkey
1050-1100    

The Clinical Impacts of Pathological Variants in BCG Response

Ioannis Varkarakis, Greece
1100-1110    

Predictive Markers of BCG Response

Murat Bozlu, Turkey
1110-1120    

Immunotherapy in Non-Muscle Invasive Bladder Cancer

Özcan Yıldız, Turkey
1120-1130    

Discussion

1130-1150  

Break

1150-1305    

Session 2- Diagnosis and Treatment of Urothelial Cancer-1

Moderators
Nikolaos Ferakis, Greece
Ahmet Yaser Müslümanoğlu, Türkiye
1150-1205    

Imaging Modalities in Staging Bladder Cancer Prior to Radical Cystectomy

Joseph Ischia, Australia
1205-1225    

Debate: The Optimal Local Treatment for Muscle Invasive Bladder Cancer

1205-1215    

Trimodality Treatment

Discussant: Hale Başak Çağlar, Türkiye
1215-1225    

Radical Cystectomy

Oner Sanli, Turkey
1225-1235    

Discussion

1235-1250    

Robotic-Assisted Radical Cystectomy Versus Open Radical Cystectomy

Joseph Ischia, Australia
1250-1305    

Biomarker-Based Approach to Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer

Peter Black, Canada
1305-1345    

Lunch

1345-1430    

Case Panel Discussion: Challenging Cases in Bladder Cancer

Abdurrahim Isikdogan, Turkey
Moderator: Tarık Esen, Türkiye
Panelists
Hale Başak Çağlar, Türkiye
Joseph Ischia, Australia
Özgür Özyılkan, Turkey
Altuğ Tuncel, Turkey
1430-1545    

Session 3- Diagnosis and Treatment of Urothelial Cancer-2

Moderators
Eyüp Gümüş, Turkey
Abdurrahim İmamoğlu, Türkiye
Özgür Özyılkan, Turkey
1430-1445    

What Is the Ideal Time to Start Immunotherapy in Metastatic Muscle Invasive Bladder Cancer?

Mehmet Artaç, Turkey
1445-1515    

How Can We Improve the Functional Outcomes in Radical Cystectomy?

1445-1455    

(Is still) Prostate Sparing Approach

Yılmaz Aslan, Turkey
1455-1505    

Robotic Nerve Sparing Radical Cystectomy – Why Do I Recommend?

Ali Fuat Atmaca, Turkey
1505-1515    

Open Nerve Sparing Radical Cystectomy

Özdal Dillioğlugil, Turkey
1515-1525    

Discussion

1525-1545    

Debate: Is There a Role of Metastasectomy in Urothelial Cancer?

Pro: Selçuk Sahin, Türkiye
Con: Fatih Köse, Turkey
1545-1605  

Break

1605-1705    

Best Presentations in EUA 2019

Moderators
Mahmut Gümüş, Türkiye
Ali Ihsan Taşçı, Türkiye
   

Video Presentation: Robot-assisted transvesical simple prostatectomy with simultaneous bladder stone removal

Presenter: Fatih Atug, Turkey
   

Video Presentation: Robotic partial nephrectomy of hilar kidney tumor non-ischemic and selective clamping technique

Presenter: Volkan Tuğcu, Türkiye
   

Video Presentation: Kadın Hastada Laparoskopik Radikal Sistektomi ve Nose (Natural Orifis Spesimen Extraction)

   

Oral Presentation: The Effect of The Endothelial Nitric Oxide Synthase Gene Polymorphisms on The Recurrence and Progression in Bladder Cancer: Long-Term Results

Presenter: Mustafa Kadıhasanoğlu, Türkiye
   

Oral Presentation: The Outcomes of Perineoscopic Radical Prostatectomy

Presenter: Yavuz Onue Danacıoğlu, Turkey
   

Oral Presentation: The Association Between Serum ENDOCAN Level and Stage, Grade of Bladder Cancer

Presenter: Mustafa Kadıhasanoğlu, Türkiye
   

Poster Presentation: Impact of Systemic Immune-Inflammation Index in Muscle Invasive Bladder Cancer: Initial Results of Single Centre

   

Poster Presentation: The Relationship Between Prostate Adenocarcinoma Immunhistochemical Expression Level of CD47 and Stage of Disease

   

Poster Presentation: Examination of oncological outcomes of patients who underwent radical nephroureterectomy and bladder cuff resection due to upper urinary system urothelial cancers

Presenter: Erdem Koç, Turkey
1705-1755    

B2B Session in EUA 2019

Moderators
Archil Chkhotua, Georgia
Başak Öven, Turkey
1705-1725    

Variants and New Entities of Bladder Cancer

Gözde Kır, Turkey
1725-1800    

Hot Topics and Clinical Reflections

1725-1735    

Bladder Cancer

Emrah Yürük, Turkey
1735-1745    

Metastatic Prostate Cancer

Fatih Selçuk Biricik, Turkey
1745-1755    

Renal Cancer

Volkan Tuğcu, Türkiye

1250-1700

SYMP-01: Joint SIU-CUA Symposium  

Room: Ypsilon I-II-III
Co-Chairs: Jean de la Rosette, Türkiye / Yinghao Sun, China
1250-1300    

Welcome

Jean de la Rosette, Türkiye
Yinghao Sun, China
1300-1400    

Prostate Imaging

Moderators
Athanasios Dellis, Greece
Peter Pinto, United States
Yinghao Sun, China
1300-1315    

MRI Imaging for PCa: Replacing Biopsies?

Qingsong Yang, China
1315-1330    

PET Imaging of Prostate Cancer

Tarık Esen, Türkiye
1330-1345    

Biopsy Strategies in China

Lei Li, China
1345-1400    

Advances in Prostate Ultrasound for Prostate Cancer

Hendrik Heers, Germany
1400-1500    

BPH

Moderators
Charalampos Konstantinidis, Greece
Rolf Muschter, Germany
Li-Ping Xie, People's Republic of China
1400-1415    

Guidelines for Conservative Management

Guosheng Yang, China
1415-1430    

Robotics in BPH Management

Nuno Pereira-Azevedo, Portugal
1430-1445    

How to Best Surgically Treat a Big Prostate in 2020

Zhankui Jia, China
1445-1500    

Prostatic Devices: Indications and Outcomes

Henry Woo, Australia
1500-1600    

Prostatitis

Moderators
Christos Alamanis, Greece
Koenraad van Renterghem, Belgium
Shujie Xia, China
1500-1515    

Diagnostic Test in Prostatitis

Jiahua Pan, China
1515-1530    

Treatment Strategies in Prostatitis

Panagiotis Mourmouris, Greece
1530-1545    

Relation Between Prostatitis and BPH

Tie Zhou, China
1545-1600    

Which AB Protocol for Prostate Biopsies?

Eddie Chan, Hong Kong
1600-1700    

Prostate Cancer

Moderators
Xavier Cathelineau, France
Alivizatos Gerasimos, Greece
Yiran Huang, China
1600-1615    

Update from Chinese Prostate Cancer Network

Shancheng Ren, China
1615-1630    

The Many Faces of AS: The Good – The Bad – The Ugly

Laurence Klotz, Canada
1630-1645    

Focal Therapy: In Whom and How?

Baijun Dong, China
1645-1700    

Robotic Surgery Is the Best

Yaşar Özgök, Turkey

1350-1700

SYMP-02: Arab Urology Around the World  

Room: Ypsilon IV-V
Co-Chairs: Jean de la Rosette, Türkiye / Yasser Farahat, United Arab Emirates
1350-1400    

Introduction

Jean de la Rosette, Türkiye
Yasser Farahat, United Arab Emirates
1400-1500    

Urinary Tract Infections

Moderators
Stavros Charalampous, Cyprus
Mohamad Eissa, Egypt
Seiji Naito, Japan
1400-1415    

Chronic UTI in Young Women – How to Treat and Outcomes

Riyad Al Mousa, Saudi Arabia
1415-1430    

Chronic UTI in Post-Menopausal Women – How to Treat and Outcomes

Patrick Coloby, France
1430-1445    

Chronic UTI in Pediatric – Diagnosis and Treatment

Hisham Ibrahim, Egypt
1445-1500    

Chronic UTI in Neobladders

Charalampos Konstantinidis, Greece
1500-1600    

Erectile Dysfunction

Moderators
Nibbras Al-Hamdani, Iraq
Alex Danso, Zimbabwe
1500-1515    

Testosterone Substitution – Is It Safe?

Waleed Alameh, Lebanon
1515-1530    

PDE5 Inhibitors: In Whom and Which One

Kostas Rokkas, Greece
1530-1545    

Treatment Strategy Following ED After Radical Prostatectomy

Ahmad Shamsodini, Qatar
1545-1600    

Penile Implant and Patient Reported Outcomes

Faysal Yafi, United States
1600-1700    

Male Voiding Problems

Moderators
Abdulqadir Alzarooni, United Arab Emirates
Joyce Baard, The Netherlands
Charalampos Mamoulakis, Greece
1600-1615    

Medical Management: Which One and for Whom?

Abdul Naser Shunaigat, Jordan
1615-1630    

Urolift and Similar Devices Are Not for Everyone!

Dean Elterman, Canada
1630-1645    

TURP Is Still the Gold Standard

Husain Alenezi, Kuwait
1645-1700    

Do We Need Aquablation or Rezum?

Mauro Gacci, Italy

1350-1700

SYMP-03: Joint SIU-IUA Symposium  

Room: Aphrodite III
Co-Chairs: Abbas Basiri, Iran / Luc Valiquette, Canada
1350-1400    

Welcome Remarks

Abbas Basiri, Iran
Luc Valiquette, Canada
1400-1445    

Nightmares in Laparoscopy

Nicolae Crisan, Romania
Akbar Nouralizadeh, Iran
1445-1530    

Nightmares in Endourology

Samuel Chi-Hang Yee, Hong Kong
1530-1615    

Hypospadias Case Discussion

Gunter De Win, Belgium and UK
Discussant: S Mohammad Ghahestani, Iran
1615-1700    

Locally Advanced Prostate Cancer Case Discussion

M Ayati, Iran
Patrick Coloby, France

Thursday, October 17

Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.

0715-1625

SYMP-04: World Urological Oncology Federation Symposium    

Room: Omikron
Co-Chairs: Peter Hammerer, Germany / Laurence Klotz, Canada
0715-0725    

Welcome & Introductions

0715-0745    

Meet and Greet International Colleagues


1

Coffee served. For WUOF attendees only.

0745-0750    

Framing of Theme

Laurence Klotz, Canada
0750-0955    

Session One | Early Detection and Treatment of Localized Prostate Cancer

Moderators
Arturo Mendoza-Valdes, Mexico
Asif Yildirim, Türkiye
0755-0810    

An Epidemiologist’s View of Prostate Cancer Screening

Sigrid V. Carlsson, United States
0810-0825    

Early Detection of Prostate Cancer in a Resource Constrained Environment

Robin Roberts, Bahamas
0825-0840    

The Impact of Positive Surgical Margins, Biochemical Recurrence or PSA Persistence on Oncological Outcomes after Radical Prostatectomy

Derya Tilki, Germany
0840-0855    

Strengths and Limitations of PSMA PET

Joseph Ischia, Australia
0855-0900    

Discussion

0910-0925    

nmCRPC - Does It Exist?

Boris Hadaschik, Germany
0925-0945    

Debate: Does RP Have a Role in the Management of Oligomets?

Pro: R. Jeffrey Karnes, United States
Con: Özdal Dillioğlugil, Turkey
0945-0955    

Discussion

0955-1010    

Coffee Break

1010-1110    

Session Two | Prostate Cancer Management Options

Moderators
Shrawan Kumar Singh, India
Ofer Yossepowitch, Israel
1015-1030    

Salvage Lymphadenectomy in the PSMA Era: Where to Draw the Line?

Axel Heidenreich, Germany
1030-1045    

Update on ADT in the Androgen Receptor Axis Targeted Therapy Era

Mehmet Ali Nahit Sendur, Turkey
1045-1100    

Chemotherapy and ARATs vs Metastases-Directed Therapy for mHSPC

Markus Graefen, Germany
1100-1110    

Discussion

1110-1240    

Session Three | Renal Cancer

Moderators
Alexandra Colquhoun, United Kingdom
Laurence Klotz, Canada
1115-1130    

Cytoreductive Nephrectomy — Has it Had Its Day?

Alessandro Volpe, Italy
1130-1145    

Management of RCC Caval Thrombus in 2019

Amlesh Seth, India
1145-1200    

Adjuvant Therapy for High Risk RCC: Current Status

Ricardo Rendon, Canada
1200-1210    

Discussion

1210-1225    

SPECIAL LECTURE: POWER POINT 101. Fumble at the Goal Line: How Presenters Hijack Attention and Lose Their Audience

Michael Leveridge, Canada
1225-1305    

Working Lunch


1

Meal voucher required. Complimentary meal to all seated participants attending Session Four Working Lunch.

1305-1320    

Session Four | The Internationals

Moderators
Jean de la Rosette, Türkiye
Laurence Klotz, Canada
   

Introduction

Laurence Klotz, Canada
1305-1315    

History and Impact of ICUDs

Luc Valiquette, Canada
1315-1320    

Molecular Biomarkers in Urologic Oncology: 2020 ICUD

Laurence Klotz, Canada
1320-1515    

Session Five | Town Hall – Innovation and the Molecular Revolution

Moderators
Jean de la Rosette, Türkiye
Laurence Klotz, Canada

Panelists
Michael Bates, Australia
Peter Black, Canada
Peter Carroll, United States
Calvin Chao, United States
Christopher Evans, United States
Wim Van Criekinge, Belgium
1320-1330    

Co-moderator Introduction

Jean de la Rosette, Türkiye
Laurence Klotz, Canada
1330-1350    

Special Guest Lecture: How Can Urologists Ensure Innovation in Urologic Oncology?

Peter Carroll, United States
1350-1400    

Lessons Learned in the Academic-Industry Partnership in Prostate Cancer Translational Research

Christopher Evans, United States
1400-1410    

Next Generation Biomarkers and Integration of Different Diagnostics Modalities (Clinical/Molecular/Imaging)

Wim Van Criekinge, Belgium
1410-1420    

Cost of Innovation in Medicine

Peter Black, Canada
1420-1430    

Global Access to Molecular Diagnostics for Urothelial Cancers on a Distributed, Automated Platform

Michael Bates, Australia
1430-1440    

How to Facilitate Collaboration to Ensure the Generation of Clinically Relevant Data

Calvin Chao, United States
1440-1500    

Open Discussion

1500-1515    

Session Six | Germ Cell Tumours

Moderator: Badrinath Konety, United States
   

Update on the Management of Complex Germ Cell Tumors

Sia Daneshmand, United States
1520-1625    

Session Seven | Advanced Prostate Cancer Treatment Options

Moderator: Badrinath Konety, United States
1525-1540    

Role of Estrogen in the Management of Prostate Cancer

Leonardo O. Reis, Brazil
1540-1555    

Theranostic Application of PSMA-Labeled Lutetium-177

Tarık Esen, Türkiye
1555-1610    

Translational Approaches to Targeting the Androgen Axis in CRPC

Christopher Evans, United States
1610-1625    

Discussion

   

Adjourn

0730-1500

LS: SIU Live Surgery    

Room: Ballroom II -III
OR Coordinators: Mustafa Boz, Turkey / Rahim Horuz, Türkiye / Pilar Laguna, Türkiye
Panel Coordinators: Anastasios Anastasiadis, Greece / Joyce Baard, The Netherlands / Ranan Dasgupta, United Kingdom

At the conclusion of this eGrand Rounds, participants should be able to:

  •  Learn about emerging procedures in the area of robotics in oncology
  • Apply practical tips and tricks to surgical techniques for robotic oncological procedures such as MRI-fusion biopsies, robotic prostatectomy, transperineal radical prostatectomy and IRE focal therapy
  •  Recognize important considerations in the surgical techniques for reconstruction surgery such as posterior urethroplasty, bulbar urethroplasty, and penile prosthesis
  •  Select the best reconstruction approach for complex cases
  •  Demonstrate practical knowledge related to the techniques in instrumentation for upper and lower urinary tract cases via surgical and emerging minimally invasive approaches
0730-0930    

Oncology-Robotics

Moderators
Rafael Coelho, Brazil
Tarık Esen, Türkiye
Koon Ho Rha, South Korea
Ioannis Varkarakis, Greece
Nianzeng Xing, China
   

Surgeries:

   

MRI-US Fusion Biopsies

Surgeon: Baris Bakir, Türkiye
   

Robotic Radical Prostatectomy

Surgeon: Mevlana Derya Balbay, Türkiye
   

Transperineal Radical Prostatectomy

Surgeon: Selami Albayrak, Türkiye
   

IRE Focal Therapy

Surgeon: Luca Lunelli, France
0930-1130    

Reconstructive Surgery

Moderators
Andre Cavalcanti, Brazil
Justin Chee, Australia
Oktay Demirkesen, Turkey
Margit Fisch, Germany
   

Surgeries:

   

Posterior Urethroplasty

Surgeons
Pankaj Joshi, India
Anthony Mundy, United Kingdom
   

Bulbar Urethroplasty

Surgeons
Stella Ivaz, United Kingdom
Anthony Mundy, United Kingdom
   

Penile Prosthesis

Surgeon: David Ralph, United Kingdom
1130-1330    

Endourology Upper Tract 

Moderators
Vitor Cavadas, Portugal
Vineet Gauhar, Singapore
Ravindra Sabnis, India
İsmet Yavaşcaoğlu, Türkiye
   

Surgeries:

   

SMP PCNL

Surgeon: Wenqi Wu, China
   

UTUC

Surgeon: Michael Grasso, United States
   

fURS

Surgeon: Alexey Martov, Russia
   

miniPCNL

Surgeon: Andreas Skolarikos, Greece
1330-1500    

Endourology Lower Tract 

Moderators
Rolf Muschter, Germany
Ahmet Yaser Müslümanoğlu, Türkiye
Seiji Naito, Japan
Teng Aik Ong, Malaysia
Li-Ping Xie, People's Republic of China
   

Surgeries:

   

HoLEP

Surgeon: Lutfi Tunc, Turkey
   

BiTUEP

Surgeon: Lukas Lusuardi, Austria
   

Live from Hamburg:

   

Aquablation

Surgeon: Thorsten Bach, Germany

0800-1000

SYMP-05a: Indian Urology Around the World - Part 1  

Room: Ypsilon IV-V
Co-Chairs: Makarand Khochikar, India / Pradeep Rao, India
0800-0805    

Inaugural Remarks

Jean de la Rosette, Türkiye
Simon Tanguay, Canada
0805-0815    

Access in PCNL - Precision, Planning and Execution

Lokesh Sinha, India
0815-0900    

Panel: Nightmares in Endourology

Moderator: Ravindra Sabnis, India
Ajay Bhandarkar, India
Panelists
Ranan Dasgupta, United Kingdom
Deepak Kirpekar, India
S. K. Pal, India
0900-0940    

Semi Live Videos - Newer Modalities in the BPH Management

0900-0910    

Aquablation

Ravindra Sabnis, India
0910-0920    

Urolift

Ranan Dasgupta, United Kingdom
0920-0930    

Robotic Simple Prostatectomy

Pradeep Rao, India
0930-0940    

Where Do We Stand In Terms of New Modalities of BPH - An Overview

Stavros Gravas, Cyprus
0940-1000    

Debate - Who Says TURP Is Gold Standard?

Moderator: Stavros Gravas, Cyprus
   

Not Any More

Deepak Kirpekar, India
   

Yes It Is and Will Be for Years to Come

Pankaj Maheshwari, India

0800-1100

INN: SIU Innovators Symposium  

Room: Aphrodite III
Co-Chairs: Shusuke Akamatsu, Japan / Pradeep Rao, India

At the end of this session, attendees will be able to:

  • Update the most recent innovations that took place in the last 3 years in diverse areas of urology.
  • Understand the basic principles of systemic therapy for urological malignancies.
  • Understand the challenges one would face in translating an innovation into clinical application and how to overcome them.

Method: Discussion.

0800-0810    

Introduction and Tribute to Dr. Daniel Christidis

Justin Chee, Australia
Todd Manning, Australia
0810-0910    

Part 1: Top Innovations in Urology in the Last Three Years

Moderators
Shusuke Akamatsu, Japan
Peter Black, Canada
0810-0818    

BPH

Dean Elterman, Canada
0822-0830    

Robotics

Atsuro Sawada, Japan
0834-0842    

Reconstruction

Paul Chung, United States
0846-0854    

Peyronie’s

Phil Bach, Canada
0858-0906    

Endourology

Prashant Jain, India
0910-1005    

Part 2: Systemic Therapy for Dummies

Moderators
Paolo Gontero, Italy
Kilian M. Gust, Austria
0910-0920    

Androgen Axis Targeted Therapy for Prostate Cancer

Siska van Bruwaene, Belgium
0920-0930    

PARP Inhibitors in Prostate Cancer

Joseph Ischia, Australia
0930-0940    

Tyrosine Kinase Inhibitors for Renal Cancer

Ario Takeuchi, Japan
0940-0950    

Checkpoint Blockade for Renal and Urothelial Cancer

Tilman Todenhöfer, Germany
0950-1005    

Panel Discussion: Should Urologists be Administering Systemic Therapies?

Panelists
Joseph Ischia, Australia
Ario Takeuchi, Japan
Tilman Todenhöfer, Germany
Siska van Bruwaene, Belgium
1005-1100    

Part 3: Commercializing Surgical Innovation

Moderators
Andrés Hernández-Porras, Mexico
Pradeep Rao, India
1005-1015    

Commercializing Surgical Innovation: A Surgeon’s Experience

1015-1025    

Commercializing Surgical Innovation: The Industry Perspective

Reinhard Zentner, Germany
1025-1035    

Commercializing Surgical Innovation: What Urologists Need to Know About Patents

Alexander Carroux, Germany
1035-1045    

Commercializing Surgical Innovation: What Urologists Need to Know About Marketing

Michael Ahmadi, United States
1045-1100    

Panel Discussion

Panelists
Michael Ahmadi, United States
Alexander Carroux, Germany
Reinhard Zentner, Germany

0800-1200

SYMP-06: 8th Symposium on Affordable New Technologies in Urology (SANTU) and Best Affordable New Technologies in Urology Contest (BANTUC)  

Room: Aphrodite I-II
Chair: Mohammed Lezrek, Morocco
Co-Chair: Petrisor Aurelian Geavlete, Romania
Honorary Chair: Daniel Yachia, Israel
0700-0845    

ePoster Viewing

0845-0855    

Opening SANTU 8

Mohammed Lezrek, Morocco
0855-1110    

SANTU Lectures

0855-0910    

What Does it Really Mean New Endourologic Technologies in Developing Countries?

Petrisor Aurelian Geavlete, Romania
0910-0920    

Moderated ePosters

   

Does the Use of Povidone-Iodine Suppository Decrease the Infective Complications of TRUS Guided Prostate Biopsies? A Randomized Prospective Study

Presenter: Mohamad Hussien Badawy, Egypt
   

Aseel’s Operation. Is it the Magic Wand?

Presenter: Mohamed Ismail, Egypt
   

Survey of Current Practices of Intravesical Therapy in Non-Muscle-Invasive Bladder Cancer (NMIBC) Among Urologists in Karachi, Pakistan

Presenter: Muhammed Farhan, Pakistan
0920-0935    

The Scope and Limitations of Clinical Research and Innovations in Developing Countries - A Cost Analysis Perspective

Arvind Ganpule, India
0935-0945    

Moderated ePosters

   

TUR-P Phantom for Resident Surgical Training: A Home-Made Human Mimicking Model of the Prostate

Presenter: Harun Wijarnarko Kusuma Putra, Indonesia
   

Percutaneous Nephrostomies in Advanced Pelvic Malignancies Causing Ureteric Obstruction: Prolonging Life or Delaying Death?

Presenter: Srijit Banerjee, United Kingdom
   

CamPROBE: A Safe, Simple, Affordable Local Anaesthesia Transperineal Biopsy Device

Presenter: Hannah Brechka, United Kingdom
0945-0955    

Is There a Difference Between Low-cost vs. Brand-Name Catheters and Stents?

Daniel Yachia, Israel
0955-1005    

Giving Global Surgery the Boost it Desperately Needs

Graham Watson, United Kingdom
1005-1015    

Moderated ePosters

   

Waiting Times for Prostate Cancer Diagnosis at a Nigerian Teaching Hospital – A 5 Year Review

Presenter: Olufemi Akinola, Nigeria
   

Open Prostatectomy for Large Benign Prostates: Assessing Benefit of Post Operative Epidural Analgesia on Outcomes

Presenter: Albert Ukpong, Nigeria
1015-1030    

Sustainable Urologic Education in Low and Middle Income Countries: Does it Provide an Economic Benefit?

Kurt McCammon, United States
1030-1040    

Moderated ePosters

   

Reintroducing Augmented Urethroplasty as Anterior Urethral Stricture Management in Tertiary Refferal Hospital in East Java

Presenter: I Gusti Lanang Andi Suharibawa, Indonesia
   

3D Printing of Pelvic Fracture Urethral Injuries

Presenter: Sanjay Kulkarni, India
   

Moderated Video: How To Remove A Double J Stent Without Forceps: The Hook

Presenter: Mohammed Lezrek, Morocco
1



1040-1050    

Tips and Tricks of Affordable Innovation

Mohammed Lezrek, Morocco
1050-1150    

3rd Best Affordable New Technologies in Urology Contest (BANTUC)

1050-1055    

Presentation of 3rd Best Affordable New Technologies in Urology Contest (BANTUC)

Daniel Yachia, Israel
1055-1145    

Presentation of the Projects by the Finalist List

   

Glove port

   

New intraurethral self-retaining device

Presenter: Salvador Vilar Correia Lima, Brazil
   

The use of novel Zedd Scissors for Cold en Bloc Excision of Bladder Tumors

Presenter: Belthangady Monu Zeeshan Hameed, India
1113-1119    

An Improvised Surgical “Sewing Machine” for Rapid Graft Quilting and Suturing in Challenging Spaces

Dmitriy Nikolavsky, United States
1119-1125    

Endockscope: A Disruptive Endoscopic Technology

Presenters
Juan Gómez Rivas, Spain
Zhamshid Okhunov, United States
1125-1131    

A new portable, warm-up and low-cost surgical simulator–A boon for those deprived of training in MAS

1131-1137    

Irrigation-suction sheath for PCNL technique

Presenter: Di Gu, China
1135-1145    

Questions & Answers

1145-1150    

Announcement of the Results and Awards Distribution of 3rd Best Affordable New Technologies in Urology Contest (BANTUC)

Presenter: Daniel Yachia, Israel
1150-1150    

Award Distributions for the Best Moderated Poster, Best Un-moderated Poster and Best Video Presentations

Presenters
Petrisor Aurelian Geavlete, Romania
Mohammed Lezrek, Morocco
1150-1155    

Closing SANTU-8 and Invitation to SANTU-9, 2020

Petrisor Aurelian Geavlete, Romania
Mohammed Lezrek, Morocco
1155-1200    

Invitation to 4th Best Affordable New Technologies in Urology Contest (BANTUC)

Daniel Yachia, Israel

0800-1200

SYMP-07: Spanish Urology Around the World  

Room: Ypsilon I-II-III
Co-Chairs: Juan Gómez Rivas, Spain / Rafael Sanchez-Salas, Canada

This session will be in Spanish.

0800-0810    

Bienvenida e Introducción

Juan Gómez Rivas, Spain
Rafael Sanchez-Salas, Canada
   

Cáncer de Próstata

0810-0825    

Límites de la resonancia magnética en el diagnostico del cáncer de próstata

Juan Gómez Rivas, Spain
0825-0840    

Rol actual del ultrasonido transrectal en el diagnóstico del cáncer de próstata

Andrés Hernández-Porras, Mexico
0840-0855    

Prostatectomia radical en cáncer de próstata de alto riesgo. Nuevas evidencias.

Mario Álvarez-Maestro, Spain
0855-0910    

Cáncer de próstata resistente a la castración. De M0 a M1.

Álvaro Juárez, Spain
0910-0925    

Reconstrucción uretral después de prostatectomia radical

Reynaldo Gómez, Chile
0925-0940    

Discusión

0940-1055    

Cáncer Renal

0940-0955    

Estado actual de la terapia en cáncer renal localizado

David Subira, Spain
0955-1010    

Evolución de la nefrectomía parcial: del cielo abierto a la robótica

Octavio Castillo, Chile
1010-1025    

Vena cava: Abordaje robótico, paso a paso

René Sotelo Noguera, United States
1025-1040    

Carcinoma renal avanzado: Una diana en movimiento

Óscar Rodríguez Faba, Spain
1040-1055    

Discusión

   

Cáncer de Vejiga

1055-1110    

Abordaje actual del cáncer de vejiga sin invasión muscular

Estefania Linares, Spain
1110-1125    

Carcinoma urotelial del tracto superior: Nuevos métodos diagnósticos de imagen

Josep Maria Gaya Sopena, Spain
1125-1145    

Discusión

1145-1200    

Conclusiones y Despedida

0900-1600

TIPS: Tips and Tricks in Research and Publication  

Room: Athenaeum
Co-Chairs: Stavros Gravas, Cyprus / Laurence Klotz, Canada / Rajeev Kumar, India

uCARE

At the end of this session, attendees will be able to:

  • Review challenges and opportunities involved in clinical research
  • Identify pitfalls in trial design.
  • Discuss how clinicians in the developing world can increase their involvement in research
  • Summarize techniques to improve the likelihood of manuscript publication. 

SIU Academy—Training in 2020

At the end of this session, attendees will be able to:

  • Review the profile of contemporary Urology residents and their expectations and training preferences.
  • Be familiar with the training opportunities that SIU provide to its members including scholarships.
  • Understand the changes and the evolution in learning models.
  • Apply educational activities discussed in this session to maintain competence, learn about new and developing areas of Urology, and improve care of patients

Reviewing for Journals

At the end of this session, attendees will be able to:

  • Identify invitations for reviewing from genuine journals as against pseudojournals.
  • List the expectations of an editor who sends an invitation to review.
  • Enumerate reasons for accepting an invitation.
  • Perform a critical appraisal of an article.
  • Write a review report for the journal.

 

 

 

0900-1100    

uCARE

Chair: Laurence Klotz, Canada
0900-0915    

Welcome Remarks & Introduction to uCARE

Laurence Klotz, Canada
0915-0930    

Pilot Study on Ureteral Stenting: Report of Results

Joyce Baard, The Netherlands
0930-1020    

Town Hall: Global Perspectives on Research Studies

Rui Chen, China
Lukman Hakim, Indonesia
Patrick Mburugu, Kenya
Teng Aik Ong, Malaysia
Athanasios (Thanos) Papatsoris, Greece
Jae Young Park, South Korea
André van der Merwe, South Africa
1020-1045    

Challenges and Opportunities in Clinical Research: Pitfalls in Trial Design

Sigrid V. Carlsson, United States
1045-1100    

BPH Mobile App Pilot Study

Stavros Gravas, Cyprus
1100-1300    

SIU Academy: Training in 2020

Co-Chairs
Stavros Gravas, Cyprus
Kurt McCammon, United States
1100-1115    

Who is the Urology Resident and What Does He/She Want?

Julian Struck, Germany
1115-1130    

Differences in Training Across the World: The Role of SIU Programmes and Scholarships

Kurt McCammon, United States
1130-1145    

e-Learning in Urology

Sean P. Elliott, United States
1145-1200    

Simulators and HOT in Urological Education

Prokar Dasgupta, United Kingdom
1200-1215    

Social Media as an Educational Tool

Todd Manning, Australia
1215-1230    

Dissemination of Knowledge: The Example of the SIU-ERAS Programme

Stephen Williams, United States
1230-1245    

Digital Applications in Medicine

Nuno Pereira-Azevedo, Portugal
1245-1300    

Discussion

1400-1600    

Reviewing for Journals

Co-Chairs
Peter Black, Canada
Rajeev Kumar, India
1400-1410    

The Editorial Process

Rajeev Kumar, India
1410-1425    

Why Should I Spend My Time Doing a Review?

Badrinath Konety, United States
1425-1445    

What Does the Editor Expect from a Reviewer?

Alexandre de la Taille, France
1445-1510    

Doing a Good Review-Critical Appraisal

Prokar Dasgupta, United Kingdom
1510-1530    

Writing a Review Report

Peter Black, Canada
1530-1550    

Pseudojournals and How to Avoid Them

Rajeev Kumar, India
1550-1600    

Discussion

1000-1200

SYMP-08: Urological Association of Asia Symposium  

Room: Ypsilon IV-V
Chair: Shin Egawa, Japan
1000-1005    

Opening Remarks

Shin Egawa, Japan
1005-1025    

Reconstruction

Moderator: Shin Egawa, Japan
1005-1015    

Current State of Urethroplasty: How to Achieve Best Results? 

Neville Perera, Sri Lanka
1015-1025    

Urethral Stricture Problems in Asia

Sanjay Kulkarni, India
1025-1105    

Stones

1025-1035    

Ureteroscopy

Moderator: Yasser Farahat, United Arab Emirates
Petrisor Aurelian Geavlete, Romania
1035-1105    

Case Discussion: Dilemma, Controversies & Consensus in Urolithiasis 

Moderator: Ravindra Sabnis, India
Discussants
Yasser Farahat, United Arab Emirates
Petrisor Aurelian Geavlete, Romania
Rajeev Kumar, India
Anthony Chi-Fai Ng, Hong Kong
1105-1155    

Cancer

1105-1115    

Is Cytoreductive Nephrectomy for Metastatic RCC Dead?

Moderator: Masayuki Nakagawa, Japan
Masatoshi Eto, Japan
1115-1130    

Case Discussion 1: Complicated Cases in Renal Cell Carcinoma

Moderator: Teng Aik Ong, Malaysia
Discussants
Vu Le Chuyen, Vietnam
Mai Ba Tien Dung, Vietnam
Hideki Enokida, Japan
Manish Patel, Australia
Ario Takeuchi, Japan
Takafumi Yanagisawa, Japan
1130-1140    

Role of Radical Prostatectomy for Metastatic Disease

Manish Patel, Australia
1140-1155    

Case Discussion 2: How to Manage Oligometastases in Prostate Cancer?

Moderator: Manish Patel, Australia
Discussants
Renu Eapen, Australia
Peter Hammerer, Germany
Anthony Chi-Fai Ng, Hong Kong
Takafumi Yanagisawa, Japan
1155-1200    

Closing Remarks

Shin Egawa, Japan

1100-1300

SYMP-09: European Association of Urology Symposium  

Room: Aphrodite III
Chair: Arnulf Stenzl, Germany
1100-1130    

Fertility Preservation in Young Patients with Cancer

Jens Sønksen, Denmark
1130-1200    

Focal Therapy in Prostate Cancer: Is Imaging Good Enough?

Manfred Wirth, Germany
1200-1230    

Muscle-Invasive Bladder Cancer: Preserve the Bladder or Do the Job Properly?

Arnulf Stenzl, Germany

1200-1400

SYMP-10: Joint Symposium of Kenyan Association of Urological Surgeons and the South African Urological Association  

Room: Ypsilon IV-V
Chair: Kevin Ramsamy, South Africa
Co-Chairs: Shingai Mutambirwa, South Africa / Saeed R. Samnakay, Kenya
Speaker: Rirhandzu Brighton Mashava, South Africa
1200-1215    

Validation of the ERPC Calculator in a Contemporary South African Cohort

John Lazarus, South Africa
1215-1230    

Efficacy of Revision Urethroplasty at Kenyatta National Hospital, Nairobi 2013 to 2018

Willy Otele, Kenya
1230-1245    

Comparative Analysis of Kidney Stone Composition in Patients of Two Developing Countries, Ghana and South Africa: A Case Study of Renal Stones from Accra and Cape Town

Lisa Kaestner, South Africa
1245-1300    

Ureteric Stenting - Tips and Tricks

Maurice Wambani, Kenya
1300-1315    

Appropriate Urological Imaging in Sub-Saharan Africa

Shingai Mutambirwa, South Africa
1315-1330    

Varicocele Management in Kenya

Samuel N.K. Waweru, Kenya
1330-1345    

Prostate Cancer and the Internet - Fact or Fiction?

Ahmed Adam, South Africa
1345-1400    

Challenges in the Management of Bladder Extrophy in a Tertiary Setting in Kenya

Timothy Jumbi, Kenya
   

Management of Glans Penis Amputation with Primary Anastomosis and Hyperbaric Oxygen Therapy

Rirhandzu Brighton Mashava, South Africa
   

Viscoelastic Properties of Metastatic Prostate Cancer whole blood utilizing Thromboelastography & Scanning Electron Microscopy

Kevin Ramsamy, South Africa
   

Transrectal Ultrasound Biopsies; A Kenyan Experience

Charles Waihenya Githiaka, Kenya

1200-1600

SYMP-12: International Society of Reconstructive Urology Symposium  

Room: Aphrodite I-II
Co-Chairs: Guido Barbagli, Italy / Margit Fisch, Germany / Sanjay Kulkarni, India
1200-1215    

Video: Ventral Onlay Urethroplasty

Guido Barbagli, Italy
1215-1230    

Video: Vessel Preserving Urethroplasty

Reynaldo Gómez, Chile
1230-1240    

Urethral Stricture in Africa

Evelyn Mmapula Moshokoa, South Africa
1240-1250    

Video: Fossa Navicularis Urethroplasty

Dmitriy Nikolavsky, United States
1250-1300    

Training Opportunities

Saskia C Morgenstern, Germany
1300-1310    

Video: Anastomotic Urethroplasty

Erick Alejandro Ramírez Pérez, Mexico
1310-1320    

Urethrocutaneous Fistula

Krishnan Venkatesan, United States
1320-1330    

GU Reconstruction in War Victims

Faisal Alhajeri, Kuwait
1330-1345    

SIU-ICUD Consultation Recommendations for Failed Hypospadias

Gunter De Win, Belgium and UK
1345-1400    

Lotus Flap Perineal Urethrostomy

Justin Chee, Australia
1400-1415    

Artificial Sphincter after Urethroplasty

Margit Fisch, Germany
1415-1430    

Surgical Management of Pyeronies

Andre Cavalcanti, Brazil
1430-1440    

Female Urethroplasty

Anna Lawrence, New Zealand
1440-1450    

Video: Anastomotic Bulbar Urethroplasty

Allen Morey, United States
1450-1500    

Video: Panurethral Strictures

Paksi Satyagraha, Indonesia
1500-1515    

Vesico Vaginal Fistula

Igor Vaz, Mozambique
1515-1530    

Penile Transplantation

André van der Merwe, South Africa
1530-1545    

Complex Posterior Urethroplasty

Sanjay Kulkarni, India
1545-1550    

Take Home Message

Rajeev T P, India
1550-1600    

Questions and Answers

1200-1600

SYMP-11: L'urologie dans la francophonie mondiale  

Room: Ypsilon I-II-III
Co-Chairs: Patrick Coloby, France / Steeve Doizi, France / Luc Valiquette, Canada

* This session will be in French

1200-1215    

Quelle est la place de la néphrectomie chez le patient métastatique?

Frédéric Pouliot, Canada
1215-1230    

Quelle est la place de l'urologue dans le traitement médical du patient métastatique?

Pierre Sarkis, Lebanon
1230-1245    

Le rôle de la biopsie pour la prise en charge des petites masses rénales au Canada

Patrick Richard, Canada
1245-1300    

Développement de la NLPC en Algérie

Hichem Kouicem, Algeria
1300-1315    

URS souple et complications : revue de la littérature

Steeve Doizi, France
1315-1330    

Laser thulium fibré : « le nouveau venu »

Etienne Xavier Keller, Switzerland
1330-1345    

L’IRM prostatique avant biopsie améliore-t-elle le taux de détection du cancer de la prostate?

Jean-Luc Descotes, France
1345-1400    

Dépistage du cancer de la prostate dans les pays du Maghreb en 2019 : quelle politique?

Abdenbi Joual, Morocco
1400-1415    

Traitement du cancer de la prostate au Cameroun en 2019

Cyril Kamadjou, Cameroon
1415-1430    

Pénurie du BCG dans la TVNIM dans le monde en 2019 : quelles sont les souches disponibles? Sont-elles équivalentes?

Thierry Roumeguère, Belgium
1430-1445    

Quelle dérivation après cystectomie chez l’homme et la femme au Maghreb en 2019?

Walid Kerkeni, Tunisia
1445-1500    

Fistule vésico-vaginale (FVV) en Afrique francophone subsaharienne : techniques opératoires et formation des chirurgiens

Serigne Magueye Gueye, Senegal
1500-1600    

Discussion de cas cliniques

1300-1600

SYMP-13: Joint SIU-KUA Symposium  

Room: Aphrodite III
Chair: Sung Kyu Hong, South Korea
1300-1310    

Welcome Address by KUA & SIU President

Kyu-Sung Lee, South Korea
Simon Tanguay, Canada
1310-1355    

Session I

Moderators
Serigne Magueye Gueye, Senegal
Jun Hyuk Hong, South Korea
1310-1320    

Successful Transition from Childhood to Adulthood: Medical Issues in the Adult Spina Bifida Patient Across the Lifespan

Minki Baek, South Korea
1320-1330    

Extended Spectrum Beta-Lactamase (ESBL) Producing Enterobacteriaceae in Korea

Seung Ki Min, South Korea
1330-1340    

Extracellular Vesicles as a Potential Therapy for Erectile Dysfunction

Ji-Kan Ryu, South Korea
1340-1355    

Discussion

Panelists
Minki Baek, South Korea
Seung Ki Min, South Korea
Jae Shin Park, South Korea
Kwanjin Park, South Korea
Ji-Kan Ryu, South Korea
1355-1440    

Session II

Moderators
Sean P. Elliott, United States
Kyu-Sung Lee, South Korea
1355-1405    

Are Synthetic Slings for Female POP and SUI Coming to an End?

Jae Hyun Bae, South Korea
1405-1415    

Interstitial Cystitis - What is New in Diagnosis and Treatment

Hana Yoon, South Korea
1415-1425    

Surgery for BPH - What Do Guidlines Recommend in 2019?

Stavros Gravas, Cyprus
1425-1440    

Discussion

Panelists
Jae Hyun Bae, South Korea
Myung-Soo Choo, South Korea
Stavros Gravas, Cyprus
Jang Hwan Kim, South Korea
Eun Sang Yoo, South Korea
Hana Yoon, South Korea
1440-1525    

Session III

Moderators
Paolo Gontero, Italy
Young Goo Lee, South Korea
1440-1450    

How Can Unnecessary Biopsies Be Reduced?

Jurgen Fütterer, The Netherlands
1450-1500    

Immunotherapy-Based Combination Therapy: Is It New Horizon for mRCC?

Woong Kyu Han, South Korea
1500-1510    

Adjuvant Treatment in NMIBC: Where Are We?

Seok Ho Kang, South Korea
1510-1525    

Discussion

Panelists
Jurgen Fütterer, The Netherlands
Woong Kyu Han, South Korea
Sung Kyu Hong, South Korea
Seok Ho Kang, South Korea
Kyung Seop Lee, South Korea
Sung Woo Park, South Korea

1400-1600

SYMP-14: Pan African Urological Surgeons Association Symposium  

Room: Ypsilon IV-V
Chair: Mohamed Jalloh, Senegal
1400-1520    

Session I: Urinary Schistosomiasis

Moderators
Kasonde Bowa, Zambia
Serigne Magueye Gueye, Senegal
1400-1415    

Sequelae of Urogenital Schistosomiasis in Senegal: Clinical Presentation

Boubacar Fall, Sénégal
1415-1430    

Urological Presentation of Schistosomiasis in Zambia

Kasonde Bowa, Zambia
1430-1445    

Schistosomiasis and Bladder Cancer in Mali

Honoré Berthé, Mali
1445-1505    

Schistosomiasis and Bladder Cancer: Evidence Based Facts?

Mohamed Jalloh, Senegal
1505-1520    

Questions and Answers

1520-1600    

Session II: Genital Filariasis

Moderators
Alex Danso, Zimbabwe
Alexander M.E. Nwofor, Nigeria
1520-1535    

Scrotal Filariasis: Experience in Yaounde Central Hospital

Achille Aurèle Mbassi, Cameroon
1535-1550    

Genital Lymphoedema: The Ghana Experience

Ben Adusei, Ghana
1550-1600    

Questions and Answers

1430-1455

SIU@U: SIU@U Studio Session: uTalks - Applying Mobile Health Technology to Clinical Practice    

Room: SIU@U Studio
Speaker: Michael Borofsky, United States

This session will not have a live audience, but will be recorded and made available on-demand via SIU@U.

1600-1700

SIU@U: SIU@U Studio Session: Sponsored Roundtable Discussion  

Room: SIU@U Studio

Friday, October 18

Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.

0800-0900

MC-01: Master Class 01—Biochemical Recurrence after Radical Prostatectomy  

Room: Aphrodite III
Co-Chairs: R. Jeffrey Karnes, United States / Derya Tilki, Germany

At the end of this session, attendees will be able to:

  • Recognize the prognostic value of biochemical recurrence.
  • Evaluate different imaging modalities available in prostate cancer patients with biochemical recurrence after radical prostatectomy.
  • Outline salvage treatment options after local treatment of prostate cancer.
  • Identify advantages and disadvantages of salvage prostatectomy.

Methods: State of the art lectures & Interactive discussions.

0800-0802    

Introduction

R. Jeffrey Karnes, United States
Derya Tilki, Germany
0814-0824    

Imaging Strategies in Prostate Cancer Patients with Biochemical Recurrence after Radical Prostatectomy

Renu Eapen, Australia
0802-0812    

Long-Term Outcomes in Patients with Biochemical Recurrence or PSA Persistence Following Radical Prostatectomy

Derya Tilki, Germany
0826-0836    

Treatment of Patients with Biochemical Recurrence after Radical Prostatectomy

R. Jeffrey Karnes, United States
0838-0848    

Oncologic Outcome and Patterns of Recurrence after Salvage Radical Prostatectomy

James Eastham, United States
0850-0855    

Discussion

0855-0900    

Summary

R. Jeffrey Karnes, United States
Derya Tilki, Germany

0800-0900

MC-02: Master Class 02—Voiding Dysfunction in Geriatric Women  

Room: VIP Lounge
Co-Chairs: Victor Nitti, United States / Satoshi Takahashi, Japan

At the end of this session, attendees will be able to:

  • Understand the pathology and mechanism of voiding dysfunction in geriatric women.
  • Discuss about the pathology and mechanism and diagnose potential pathology of the patients’ background.
  • Recognize the association between diabetes and UTI, how voiding time influence them, the best management of post-void residual, and how to treat the patients with both OAB and voiding dysfunction in elderly.
  • Categorize the patients’ background and type of voiding dysfunction in geriatric women in real-life clinical practice.
  • Manage those patients by the appropriate treatment strategy.
0800-0810    

Do Diabetes or Voiding Dysfunction Have an Impact on Urinary Tract Infection?

Satoshi Takahashi, Japan
0812-0822    

Voiding Time in Geriatric Women

Seiji Matsumoto, Japan
0824-0834    

Emptying Problems in Elderly Women: Diagnostic Challenges and Implications for Treatment

Victor Nitti, United States
0836-0846    

Challenges of Treating Overactive Bladder in the Elderly with Concomitant Voiding Dysfunction

Apostolos Apostolidis, Greece
0848-0853    

Discussion

0853-0900    

Closing Comments/Take Home Messages

Victor Nitti, United States
Satoshi Takahashi, Japan

0800-0900

MC-03: Master Class 03—Pediatrics for the General Urologist    

Room: Ypsilon IV-V
Co-Chair: Jennifer Yang, United States
Speaker: Georgios Zoupanos, Greece

At the end of this session, attendees will be able to:

  • Understand the guidelines for work up of the pediatric patient with UTI and imaging guidelines.
  • Discuss the role of bladder bowel dysfunction in pediatric UTIs and VUR.
  • Utilize cases as example for discussion.
  • Recognize Pediatric Urologic emergencies and their management.
  • Review appropriate algorithms for immediate management vs. referral.
  • Distinguish the spectrum of hypospadias variants and recognize features concerning for disorder of sex development.
  • Promote active learning through pictorial review of cases.
  • Identify specific needs of congenitalism patients.
  • Review rationale for follow up algorithms.
0800-0810    

Pediatric Urology: Not Just Little Adults

Dana Weiss, United States
0812-0822    

Pediatric Urology Emergencies

Anastasios D. Karatzas, Greece
0824-0834    

How to investigate a Pediatric Urinary Tract Infection (UTI)

Sotirios Bogris, Greece
0836-0846    

Non-Neurogenic Pediatric Incontinence

Steve Hodges, United States
0848-0853    

Discussion

0853-0900    

Closing Comments/Take-Home Message

   

Chair Speech

Chair: Georgios Zoupanos, Greece

0800-1300

PRECON-01: 9th Eurasian Uro-Oncology Congress Cont.  

Room: Omikron
Chair: M. Ihsan Karaman, Türkiye

Programme continued from Wednesday, October 16.

0800-0930    

Session 4 – Metastatic Prostate Cancer

Moderators
Atıf Akdaş, Turkey
Theodoros Kalogeropoulos, Greece
0800-0815    

Characteristics and Structural Variations of Genome in Metastatic Prostate Cancer

Christopher Evans, United States
0815-0830    

The Role of PET-CT in Metastatic Prostate Cancer – What Urologists Think?

Konstantinos Stravodimos, Greece
0830-0900    

Improving Outcome and Reducing Morbidity with ADT

Laurence Klotz, Canada
0900-0915    

Current Status of Theranostics in Prostate Cancer

Meltem Çağlar Tuncalı, Turkey
0915-0930    

Role of Immunotherapy in mCRPC: A New Hope

Timuçin Çil, Turkey
0930-1010    

Session 5 – Oligometastatic Prostate Cancer

Moderators
Selami Albayrak, Türkiye
Jean de la Rosette, Türkiye
Bülent Orhan, Turkey
0930-0940    

Urologists' Perspective

Faruk Özcan, Turkey
0940-0950    

Oncologists' Perspective

Fuat Demirelli, Turkey
0950-1000    

Radiation Oncologists' Perspective

Hale Başak Çağlar, Türkiye
1000-1010    

Discussion

1010-1030  

Break

1030-1130    

Challenging Cases in Metastatic Prostate Cancer - Case Panel Discussion

Moderators
Bülent Akduman, Türkiye
Joseph Ischia, Australia

Panelists
Cagatay Arslan, Türkiye
Fatih Atug, Turkey
Metin Özkan, Turkey
Meltem Çağlar Tuncalı, Turkey
1130-1300    

Session 6 - Renal Cancer: Locally Advanced and Metastatic

Moderators
Turhan Çaşkurlu, Türkiye
Salim Başol Tekin, Turkey
1130-1150    

Fraility in RCC

1150-1210    

Situation After CARMENA

1150-1200    

Situation After CARMENA: Urologists' Perspective

Pilar Laguna, Türkiye
1200-1210    

Situation After CARMENA: Oncologists' Perspective

Umut Kefeli, Turkey
1210-1300    

Challenging Cases in RCC

Moderator: Pilar Laguna, Türkiye
Panelists
Bulent Akduman, Turkey
Yiğit Akın, Türkiye
Faysal Dane, Turkey
Mehmet Küçüköner, Turkey
Omer Levent Tuncay, Türkiye

0830-1130

INN-03: MRI Master Class: Based on the Cambridge Prostate MRI and Biopsy Course  

Room: Theta/Sigma/Delta
Chair: Christof Kastner, United Kingdom

Overview

The quality and advantages of prostate MRI have redefined diagnostic practice in recent years. A recent publication of the Hansen BJUI papers, PROMIS and PRECISION, strongly advocates the use of multi-parametric MRI (mpMRI) for lesion detection and biopsy avoidance in the diagnostic pathway.

This established international workshop has traditionally addressed the approach to learning this new diagnostic tool on workstations in a multidisciplinary fashion involving radiologists, urologists, and pathologists.

The original Cambridge course has been delivered annually since 2013 with unanimous applause as a combined MRI & biopsy course. Components have been used successfully for numerous 1-day courses and seminars at the ECR2017, 2018 and 2019, the FT2015, 2018 and 2019, the SIU 2017 and 2018, and each year since 2013 in Cambridge as the original 2-day course.

08:30-08:35
Welcome and Introduction of Cambridge Course & Philosophy

08:35-08:50
Introduction to Prostate Cancer Diagnostics and the Role of MRI

08:50-09:10
Prostate MRI and PI-RADS

09:10-09:55
MRI Case Analysis

09:55-10:10
Abnormal Prostate MRI - Pearls & Pitfalls of Reading and Reporting

10:10-10:25
To Biopsy or Not to Biopsy – Clinical Application of Prostate MRI

10:25-10:35
Continued Learning and Introduction to MRIpro

10:35-11:30
MRI Case Analysis

This session is supported by Philips.

0900-1030

SYMP-05b: Indian Urology Around the World - Part 2  

Room: Athenaeum
Co-Chairs: Makarand Khochikar, India / Pradeep Rao, India
0900-0940    

Medical Uro-Oncology for Dummies - Practical Aspects

0900-0915    

TKIs in Kidney Cancer - Clearing the Clouds

Sumit Isharwal, United States
0915-0930    

Newer Drugs in Prostate Cancer - Which, When, Why, How?

Makarand Khochikar, India
0930-0940    

Robotic Kidney Transplant - The Future?

Rajesh Ahlawat, India
0940-1000    

Panel: Complex Renal Masses - Challenging Situations

Raghunath Krishnappa, India
Prasad Patki, United Kingdom

Moderator: Monish Aron, United States
Panelist: Rajesh Ahlawat, India
1000-1030    

Panel: Complications after Renal Transplant - Case Studies

Moderator: Ajay Oswal, India
Panelists
Deepak Dubey, India
Puneet Sindhwani, United States
Lokesh Sinha, India
   

Questions and Answers

Monish Aron, United States

0900-1030

PL-01: Plenary 01    

Room: Ballroom II -III
Honorary Chairs: Christopher Evans, United States / Rajeev Kumar, India / Simon Tanguay, Canada
0900-0905    

Welcome and SIU Academy Award

Honorary Chair: Simon Tanguay, Canada
0905-0920    

Hellenic Urological Association Lecture: Clinical Practice Guidelines: The Unmet Needs

Dionysios Mitropoulos, Greece
0920-0925    

Introduction to SIU-Mostafa M. Elhilali Award Lecture

0925-0940    

SIU-Mostafa M. Elhilali Award Lecture: Active Surveillance for Early Stage Prostate Cancer - The Future or the Past?

Peter Carroll, United States
0940-0955    

American Urological Association Lecture: The Role of Surgery in Advanced Prostate Cancer

Kelly Stratton, United States
0955-1010    

The Future of Regenerative Medicine

Gopal Badlani, United States
1010-1025    

Precision Medicine

Christopher Evans, United States
1

 

At the end of this lecture, participants will be able to:

  • Understand precision medicine in the context of individual and cohorts of genomic similarities
  • Appreciate genomic alterations in localized and advanced prostate cancer
  • Appreciate how publicly available genomic databases can be useful in research
  • Correlate genomic testing in solid tissue and liquid biopsies
1025-1030    

Discussion

1030-1100

Break in Exhibit Hall  

Room: To Be Determined

1035-1055

SIU@U: SIU@U Studio Session - Ask-the Expert: Managing your African Patients’ Bedroom Issues  

Room: SIU@U Studio
Speaker: Shingai Mutambirwa, South Africa

1100-1230

JS-01: Joint SIU-ICS Symposium  

Room: Athenaeum
Co-Chairs: Elise De, United States / Sherif Mourad, Egypt

At the end of this session, attendees will be able to:

  • Describe surgical options for neurogenic incontinence
  • Identify and give examples of reasons urodynamics are necessary in evaluation of neurogenic bladder
  • Classify neurogenic bladder dysfunction in transitional (child to adult) urology
  • Report on neuromodulation and neurostimulation for neurogenic lower urinary tract dysfunction
  • Apply knowledge regarding current treatment of rectourethral fistulae

The learner will leave the program with the ability to demonstrate competence to mastery of the above objectives as well as knowledge of where to find more information on the topics.

Methods: Didactic lectures, presentation of cases, questions and comments from the panel and the audience, and discussion of material.

1100-1125    

Panel Discussion - Scope of Surgical Treatment Strategies in Neurogenic Incontinence

Discussants
Rizwan Hamid, United Kingdom
Charalampos Konstantinidis, Greece
Philip Van Kerrebroeck, The Netherlands
1125-1140    

Debate - Urodynamics is Necessary for Follow-up Evaluation of Neurogenic Bladder

Kenneth Angermeier, United States
Discussants
David Manuel Castro Díaz, Spain
Rizwan Hamid, United Kingdom
1140-1155    

Update on Treatment of Recto Urethral Fistulae

Kenneth Angermeier, United States
1155-1210    

Neuromodulation and Neurostimulation for Neurogenic Lower Urinary Tract Dysfunction

Karl-Dietrich Sievert, Germany
1210-1225    

Neurogenic Bladder Dysfunction in Transitional Urology

Giovanni Mosiello, Italy

1100-1230

JS-02: Joint SIU-SUO/ESOU Symposium  

Room: Ypsilon I-II-III
Co-Chairs: Maurizio Brausi, Italy / Michael Cookson, United States

At the end of this session, attendees will be able to:

  • Identify the surgical approach and outcomes of radical nephrectomy in the setting of renal cell carcinoma and tumor thrombus in the inferior vena cava.
  • Describe appropriate patients for the use of neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer, and the implications of pT0 on outcomes.
  • Identify appropriate patients for consideration of focal therapy in the management of localized prostate cancer.
  • Discuss the risks, benefits, and potential harms of focal therapy for patients with localized prostate cancer.
  • Summarize results of patients with high-grade T1 bladder cancer managed with either BCG maintenance (bladder preservation) as compared to radical cystectomy.
1100-1140    

Panel Discussion: Indications for Focal Therapy in Prostate Cancer in 2018: Where Do We Stand?

Moderator: Michael Cookson, United States
Panelists
Laurence Klotz, Canada
Clement Orczyk, United Kingdom
Kelly Stratton, United States
1140-1200    

Debate Bladder Cancer: The Optimal Management for a Healthy 65 year-old Male with High Grade T1 Bladder Cancer is BCG Maintenance

Moderator: Maurizio Brausi, Italy
Pro: Paolo Gontero, Italy
Con: Seth Lerner, United States
1200-1230    

State-of-the-Art Lectures

1200-1212    

Surgical Management of Renal Cell Carcinoma with IVC Involvement

Bradley Leibovich, United States
1215-1227    

pT0 after Neoadjuvant Chemotherapy for ct2 Urothelial Carcinoma of the Bladder: Implications for Bladder Preservation

Kelly Stratton, United States

1100-1230

MVP-01: Moderated Video Session 01 - Minimally Invasive Surgery  

Room: VIP Lounge
Moderators: Andreas Skolarikos, Greece / Jack Tay, Singapore

Click here to view videos.

1100-1230

IC-01: Instructional Course 01: Statistics in Urology: Concepts for Clinicians  

Room: Lamda
Chair: Monique J. Roobol, The Netherlands

At the end of this session, attendees will be able to:

  • Get more insight in commonly used statistical techniques in the urological literature.
  • Correctly value authors’ conclusions and recommendations.
1100-1110    

Introduction and Objectives

Sigrid V. Carlsson, United States
Sebastiaan Remmers, The Netherlands
Monique J. Roobol, The Netherlands
1110-1150    

Methodology and Statistical Analysis in Practice

Sigrid V. Carlsson, United States
Sebastiaan Remmers, The Netherlands
Monique J. Roobol, The Netherlands
1150-1230    

A Guide to Reporting and Interpreting Statistics in your Scientific Manuscripts

Sigrid V. Carlsson, United States
Sebastiaan Remmers, The Netherlands
Monique J. Roobol, The Netherlands

1100-1230

IC-02: Instructional Course 02: Urological Trauma    

Room: Ypsilon IV-V
Chair: Michael Coburn, United States

During this activity, participants will be able to:

  • Become familiar with the AUA and European Practice Guidelines for the management of injuries to the kidney, ureter, bladder, urethra and external genitalia
  • Appreciate the complexities of managing penetrating injuries to the genito-urinary system
  • Develop familiarity with practical approaches to operative repair of a variety of urologic injuries, and be knowledgeable about the indication for operative vs nonoperative management
  • Understand the indications and techniques for employing “damage control” strategies for urological injuries in the unstable trauma patient
   

Presentation of SIU Academy Award Lecture for Outstanding Content

Chair: Michael Coburn, United States
   

Faculty:

Noel Armenakas, United States
Michael Coburn, United States
Allen Morey, United States
1100-1115    

Introduction/Kidney

Michael Coburn, United States
1115-1130    

Ureter

Michael Coburn, United States
1130-1145    

Bladder

Noel Armenakas, United States
1145-1200    

Urethra

Noel Armenakas, United States
1200-1215    

Genital/Military

Allen Morey, United States

1100-1230

IC-03: Instructional Course 03: Penile Prosthesis Surgery  

Room: Aphrodite III
Chair: Faysal Yafi, United States

At the end of this session, attendees will be able to:

  • Prepare and set up for various techniques of penile prosthesis surgery
  • Perform standard and complex penile prosthesis procedures
  • Evaluate and manage complications related to penile prosthesis surgery

Course Summary: Urologists in some underserved areas and developing countries have less access to and knowledge about penile prosthesis surgery which may hinder their ability to safely and efficiently offer this option to their patients. We will have 5 experienced sexual medicine/prosthetic surgery specialists reviewing all relevant pre-operative, intra-operative and post-operative issues regarding these surgeries.

1100-1100    

Introduction

Faysal Yafi, United States
1100-1110    

Overview, Work-Up and Management Options for Erectile Dysfunction

Alexander Pastuszak, United States
1110-1115    

Overview of Different Penile Prostheses

Alexander Pastuszak, United States
1115-1125    

Patient Preparation and Positioning for Penile Prosthesis Surgery

Faysal Yafi, United States
1125-1130    

Different Approaches for Penile Prosthesis Placement

Alexander Pastuszak, United States
1130-1135    

Placement of Malleable Penile Prosthesis

Tung-Chin (Mike) Hsieh, United States
1135-1145    

Prosthesis Placement in Peyronie’s Disease and Fibrosis

Tung-Chin (Mike) Hsieh, United States
1145-1155    

Different Approaches for Reservoir Placement

Faysal Yafi, United States
1155-1200    

Mini-Jupette And Dual AUS/IPP

Faysal Yafi, United States
1200-1215    

Management of Intra- and Post-Operative Complications

Lawrence Jenkins, United States
1215-1220    

Post-Operative Follow-Up

Lawrence Jenkins, United States
1220-1230    

Questions & Answers

1200-1600

INN-02: SIU Innovators MRI-TRUS Fusion Hands-On Course  

Room: Theta/Sigma/Delta
Chair: Peter Black, Canada
   

Faculty

Marc Dall'Era, United States
Boris Hadaschik, Germany
Robert Reiter, United States

1230-1400

Break and Luncheon Symposium  

Room: To Be Determined

1300-1400

SIU@U: SIU@U Studio Session: uChallenge: Residents' Rapid-Fire Q&A  

Room: SIU@U Studio
Hosts: Dean Elterman, Canada / Kevin Zorn, Canada

1300-1700

SYMP-15: Symposium on Focal Therapy  

Room: Lamda
Chair: Thomas Polascik, United States

At the end of this session, attendees will be able to:

  • Understand the various definitions of focal therapy, its potential role and feasibility in the treatment of early stage, localized prostate cancer.
  • Define the value of different imaging techniques for detecting and localizing prostate cancer foci within the gland along with the results of image-guided, multi-core biopsy providing a topographical map of the cancer.
  • Develop selection criteria for patients deemed candidates for focal therapy.
  • Understand the different ablative techniques and devices for focal therapy.
  • Understand the role of renal mass biopsy, active surveillance and focal therapy to manage the SRM.
1300-1400    

Focal Therapy Prostate Strategies

Moderators
Jean de la Rosette, Türkiye
Thomas Polascik, United States
1300-1317    

Defining Focal Therapy

Jonathan Coleman, United States
1318-1335    

Patient Selection and Biopsy Strategies

Jack Tay, Singapore
1336-1353    

Follow-Up Strategies After Prostate FT: Report from the Kyoto Consensus

Ardeshir Rastinehad, United States
1354-1400    

Take-Home Message

Thomas Polascik, United States
1400-1500    

Focal Therapy Prostate Imaging

Moderators
Peter Pinto, United States
Ardeshir Rastinehad, United States
1400-1417    

Novel Technologies in Focal Therapy

Ardeshir Rastinehad, United States
1418-1435    

mpUS - Progress Towards a Functional Non-Fusion Imaging Device

Georg Salomon, Germany
1436-1453    

mpMRI - Is the Next Step to Improve the Device or the Community Expert Reader?

John Feller, China
1454-1500    

Take-Home Message

Peter Pinto, United States
1500-1600    

Focal Therapy Prostate Treatment

Moderators
Rafael Sanchez-Salas, Canada
Osamu Ukimura, Japan
1500-1517    

HIFU Outcomes, Lessons Learned and Future Promise

Xavier Cathelineau, France
1518-1535    

Focal Cryosurgery

Andres Luis de Castro Abreu, United States
1536-1553    

Focal Laser Ablation: Patient Selection, Technique and Outcomes

John Feller, China
1554-1600    

Take-Home Message

Rafael Sanchez-Salas, Canada
1600-1700    

Focal Therapy Renal

Moderators
Pilar Laguna, Türkiye
Thomas Polascik, United States
1600-1617    

The Role of Renal Biopsy in the SRM

Mesut Remzi, Austria
1618-1635    

The Many Faces of AS

Simon Tanguay, Canada
1636-1653    

Treatment of Cystic SRM

Patrick Richard, Canada
1654-1700    

Take-Home Message

Pilar Laguna, Türkiye

1400-1530

IS-01: Interactive Session 01—Kidney Tumors    

Room: Omikron
Co-Chairs: Evangelos Liatsiko, Greece / Yoshihiko Tomita, Japan

 

At the end of this session, attendees will be able to:

  • Compare their initial assessment of several renal cancer cases with the same interpretation by an expert panel.
  • Address key safety aspects on the management of difficult renal cancer scenarios.
  • Define key differences on the assessment of the same case between different experts.  

 

Methods: Interactive discussion of several renal cancer cases by an expert panel, audience involvement, evidence-based summary as take-home message.

 

   

Case Presentation

Evangelos Liatsiko, Greece
   

Panel: Kidney Tumors

Monish Aron, United States
Petros Sountoulides, Greece
Alessandro Volpe, Italy
   

Surgery and Systematic Therapy at Immuno-Oncology Therapy Era

Yoshihiko Tomita, Japan

1400-1530

MV-01: Master Videos 01—Anterior Urethroplasty  

Room: Ballroom II -III
Co-Chairs: Margit Fisch, Germany / Sanjay Kulkarni, India

Anterior urethroplasty is an art of precision surgery performed in a frequently hostile and unfriendly surgical field. The challenges of this craft arise when immaculate exposure and dissection is required in the midst of various vessels and vital structures, with some coursing unpredictably. Ultimately, our objectives encompass the need to improve the understanding of this surgery.

At the end of this session, attendees will be able to:

  • Recognize and remedy the common pitfalls of anterior urethroplasty for application in their practice. 

We will reveal our methods of urethroplasty including:

  • The vital importance of adequate incisional length for optimal exposure of anatomy. This will tie into the dynamic nature of progressive adjustment of our retraction with each step.
  • Respect for tissue with correct atraumatic instruments.
  • Recognition of fine details and subtle visual cues to reveal the exact planes of dissection during anterior urethroplasty.
  • Harvesting the best quality graft for augmentation of the urethra, including the correctness of quilting and suturing.

The session will be interactive through a combination of thought-provoking questions and Socratic teaching methods delivered by renowned faculty. The audience will be taken through the surgeries in a step-by-step and comprehensive manner, leaving no stone unturned.

In conclusion, our audience will leave the session enlightened and confident with a thorough understanding of complex local anatomy, technical correctness and what is necessary to achieve the best possible results during anterior urethroplasty surgery.

1400-1420    

Bulbar Urethroplasty with Buccal Mucosa Onlay

Margit Fisch, Germany
1420-1440    

Non-Transection Bulbar Urethroplasty

Sanjay Kulkarni, India
1440-1500    

Penile Reconstruction through Perineal Incision

Justin Chee, Australia
1500-1520    

Two-Staged Penile Urethroplasty with Oral Graft only for the Second Step

Pankaj Joshi, India
1520-1530    

Discussion

1400-1530

MP-00: Moderated ePoster Session 00 - Outstanding Abstracts  

Room: Athenaeum

Click to view ePosters here

 

1400-1530

MP-01: Moderated ePoster Session 01 - Prostate Cancer  

Room: Ypsilon IV-V
Moderator: Charalampos Deliveliotis, Greece

Click to view ePosters here:

1400-1530

MP-02: Moderated ePoster Session 02 - Basic Science/ Infections  

Room: Ypsilon I-II-III

EPoster listing available to view here.

1400-1530

MVP-02: Moderated Video Session 02 - BPO/LUTS  

Room: VIP Lounge
Moderators: Athanasios Dellis, Greece / Claus Roehrborn, United States / Rajeev T P, India

Click here to view list of video ePosters.

1400-1530

IC-04: Instructional Course 04: MRI Reading for Prostate Cancer  

Room: Aphrodite III
Chair: Christof Kastner, United Kingdom

 

At the conclusion of this activity, participants will be able to:

  • Understand the descriptions and terminology used to report Prostate mpMRI
  • Explain principles and evidence of MRI-based prostate assessment including biopsies
  • Apply the various roles mpMRI-based assessment in their day-t0-day practice based on quality management processes
   

Speakers:

Tristan Barrett, United Kingdom
Jurgen Fütterer, The Netherlands
1400-1430    

Descriptions and terminology used to report Prostate mpMRI

Tristan Barrett, United Kingdom
1430-1500    

Principles and Evidence of MRI-based Prostate Assessment Including Biopsies

Tristan Barrett, United Kingdom
1500-1530    

mpMRI-based Assessment in Day-to-Day Practice

Christof Kastner, United Kingdom

1530-1545

Break in Exhibit Hall  

Room: To Be Determined

1545-1715

CONT-01: Controversies in Urology 01—Bladder Cancer    

Room: Omikron
Co-Chairs: Badrinath Konety, United States / Andrea Necchi, Italy

At the end of this session, attendees will be able to:

  • Understand and apply new markers in the evaluation and management of non muscle invasive bladder cancer.
  • Understand the indications and complications of systemic immunotherapy as well as chemotherapy for bladder cancer.
  • Discuss the indications and application of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer.
1545-1615    

Debate 1—NMIBC: Intravesical Therapy

1545-1600    

Urinary Markers Are Useful in Management of Bladder Cancer

Wei Shen Tan, USA
1600-1615    

Urinary Markers Are Irrelevant for Management of Bladder Cancer

Renu Eapen, Australia
1615-1645    

Debate 2—Immuno vs. Chemotherapy as Neoadjuvant Therapy for MIBC

1615-1630    

Immunotherapy

Andrea Necchi, Italy
1630-1645    

Chemotherapy

Roland Seiler-Blarer, Switzerland
1645-1715    

Debate 3—Neoadjuvant vs Adjuvant Therapy for MIBC

1645-1700    

Neoadjuvant

Petros Grivas, United States
1700-1715    

Adjuvant

Mark Soloway, United States

1545-1715

MV-02: Master Videos 02—PCNL and fURS: State of the Art Techniques  

Room: Ballroom II -III
Co-Chairs: Madhu Sudan Agrawal, India / Ranan Dasgupta, United Kingdom

At the end of this session, attendees will be able to:

  • Develop their own algorithm to manage patients with urolithiasis of the upper tract, by looking at various options for the same problem,
  • Deciding the best percutaneous as well as retrograde approach for a given clinical situation.

Methods: Discussion.

1545-1550    

Introduction and Welcome

Madhu Sudan Agrawal, India
Ranan Dasgupta, United Kingdom
1550-1610    

Stone Treatment by URS

Vitor Cavadas, Portugal
1610-1630    

Indications for Supine PCNL

Ranan Dasgupta, United Kingdom
1630-1650    

Masterclass Mini PCNL

Madhu Sudan Agrawal, India
1650-1710    

PCNL in Abnormal Anatomy

Ravindra Sabnis, India
1710-1715    

Conclusions and Future Directions

Ranan Dasgupta, United Kingdom

1545-1715

MP-03: Moderated ePoster Session 03 - BPH/Voiding Dysfunction  

Room: Ypsilon I-II-III
Moderators: Apostolos Apostolidis, Greece / Noel Armenakas, United States / Karl-Dietrich Sievert, Germany

ePoster listing is available to view here.

1545-1715

MP-04: Moderated ePoster Session 04 - Prostate Cancer  

Room: Ypsilon IV-V
Moderators: Axel Heidenreich, Germany / Petros Sountoulides, Greece / Derya Tilki, Germany

ePoster listing is available to view here.

1545-1715

MP-05: Moderated ePoster Session 05 - Miscellaneous/ Education  

Room: Athenaeum
Moderators: Dimitrios Hatzichristou, Greece / Jennifer Yang, United States

ePoster listing available to view here.

1545-1715

MVP-03: Moderated Video Session 03 - Reconstruction and Prostate Cancer  

Room: VIP Lounge
Moderators: Peter Carroll, United States / Kevin Lu, Taiwan

Click to view list of video ePosters here.

1545-1715

IC-05: Instructional Course 05: Gender Affirmation Surgery - From Beginning to the End  

Room: Aphrodite III
Chair: Miroslav Djordjevic, Serbia

At the end of this session, attendees will be able to:

  • Define modalities of gender affirmation surgery and their advantages and disadvantages.
  • Conduct proper preoperative assessment and preparation of the patient for surgery.
  • Recognize most important surgical steps in male-to-female and female-to-male gender affirmation surgery; define and achieve successful outcome.
  • Conduct good postoperative care and treatment.
  • Identify pitfalls and resolve postoperative complications.
1545-1605    

Pitfalls in Gender Affirmation Surgery

Miroslav Djordjevic, Serbia
1605-1625    

Gender Affirmation Surgery - Bioethical Aspects

Borko Stojanovic, Serbia
1625-1645    

Male to Female Gender Affirmation Surgery

Daniel Dugi, United States
1645-1705    

Female to Male Gender Affirmation Surgery

Marta Bizic, Serbia
1705-1715    

Questions and Answers

1730-1755

SIU@U: SIU@U Studio Session: Sponsored uTalks    

Room: SIU@U Studio
   

Clinical Experience with High Resolution 29MHz Micro-Ultrasound

Laurence Klotz, Canada

Saturday, October 19

Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.

0700-0800

GA: SIU General Assembly  

Room: Ypsilon I-II-III

0800-0900

MC-04: Master Class 04—Challenges in Testis Cancer Care  

Room: Ypsilon IV-V
Co-Chairs: Peter Albers, Germany / Sia Daneshmand, United States

At the end of this session, attendees will be able to:

  • Describe the treatment options for small testicular masses.
  • Interpret the difference in treatment for early stage seminomas
  • Distinguish between unilateral versus bilateral template resection for post-chemotherapy RPLND
  • Through case-based discussions, participant will determine the best surgical treatment option for patients with late relapse of germ cell tumors.
0800-0810    

Small Testicular Mass: Diagnosis, Treatment, Organ-Sparing Surgery

Axel Heidenreich, Germany
0812-0822    

Early Stage Seminoma (Stage I-IIB): Is Active Surveillance Always the Standard?

Joost Boormans, The Netherlands
0824-0834    

Postchemotherapy RPLND: Unilateral or Bilateral Template Resection?

Peter Albers, Germany
0836-0846    

Late Relapse: Surgical Strategies

Sia Daneshmand, United States
0848-0854    

Audience Response and Discussion

0854-0900    

Summary

Peter Albers, Germany
Sia Daneshmand, United States

0800-0900

MC-05: Master Class 05—Male Infertility  

Room: Athenaeum
Co-Chairs: Yacov Reisman, The Netherlands / Nikolaos Sofikitis, Greece

This course provides state-of-the-art information on urological and sexological aspects related to therapy of male infertility. In terms of therapy, this course will provide updated information on evidence-based data and will discuss the importance and indications of micro-surgery. De indications and preferred skills for vasectomy and reversal. The available evidence for the prescription of pharmaco-therapy of infertile male will be discussed and male sexual dysfunctions related to infertility will be reviewed.

At the end of this session, attendees will be able to:

  • Define the right indications for micro-surgery in infertile male.
  • Apply the right indication and right approach for vasectomy and reversal.
  • Determine if there is enough evidence for the use of pharmacotherapy for infertility.
  • Recognize, diagnose and manage male sexual dysfunctions which are related to male infertility.
0800-0812    

Vasectomy and Reversal: When and How

Marij Dinkelman-Smit, The Netherlands
0812-0824    

Indications for Microsurgery in the Non-Obstructed Infertile Male

Nikolaos Sofikitis, Greece
0824-0836    

Is There an Evidence-Based Medicine Supporting the Usage of Pharmaceutical Agents for the Treatment of the Infertile Male

Rajeev Kumar, India
0836-0848    

Male Sexual Dysfunction and Infertility

Yacov Reisman, The Netherlands
0848-0855    

Discussion

0855-0900    

Summary

Yacov Reisman, The Netherlands
Nikolaos Sofikitis, Greece

0800-0900

MC-06: Master Class 06—PET Imaging in Urologic Cancer    

Room: Omikron
Chair: Henry Woo, Australia

At the end of this session, attendees will be able to:

  • Identify various PET tracers available for use in prostate cancer staging, and comparative results between each tracer.
  • Understand the role of PET PSMA to better localise prostate cancers pre and post biopsy
  • Understand therole of PET tracers in other urological malignancies
  • Understand the role of PET PSMA theranostics in the management of metastatic prostate cancer

Methods: Didactic lectures, discussion, and audience participation.

0800-0802    

Introduction

Henry Woo, Australia
0802-0812    

PET Imaging in M0 CRPC

Joseph Ischia, Australia
0814-0824    

PET Imaging in RCC and Urothelial Cancers

Eoin MacCraith, Ireland
0826-0836    

PET vs MRI directed Prostate Biopsy

Laura Izquierdo Reyes, Spain
0838-0848    

PET directed Theranostics

Renu Eapen, Australia
0850-0855    

Additional Questions from Audience

0855-0900    

Summary and Close

Henry Woo, Australia

0800-1530

NURS: 5th SIU Global Nurses' Educational Symposium    

Room: VIP Lounge
Chair: Kay Talbot, Australia
0800-0805    

Welcome

Kay Talbot, Australia
0805-0825    

All about BPH

Moderators
Vashti Livingston, United States
Kay Talbot, Australia

Jaspreet S. Sandhu, United States
0825-0804    

Living with Urinary Symptoms—Strategies to Improve Continence

0845-0945    

The Transgender Setting – Urological Challenges for the Patient

Sharon Fillingham, United Kingdom
Maurice Garcia, United States
0945-1045    

Let’s Not Reinvent the Wheel - How to Adopt Existing Evidence-Based Guidelines Internationally with Nurse's Panel

Dionysios Mitropoulos, Greece
Panelists
Sharon Fillingham, United Kingdom
David Heath, Australia
Vashti Livingston, United States
1045-1100    

Morning Tea Break (in room) & Viewing of ePosters

1100-1115    

Moderated ePosters

   

The Application of ERAS Protocol in the Treatment of Patients Under Robot Assisted Laparoscopic Prostatectomy

Presenter: Ding Yan, China
   

Effect of Warm Bladder Irrigation Fluid for Benign Prostatic Hyperplasia Patients on Perioperative Hypothermia, Blood Loss and Shiver: A Meta-Analysis

Presenter: Ding Yan, China
   

Homeflow: Comfort of Uroflowmetry At Home with Children - A Feasibility Study

Presenter: Gunter De Win, Belgium and UK
1115-1155    

Oral Abstract Presentations

   

Decision-Making Style and Influencing Factors of Patients with Prostatectomy

Ding Yan, China
   

Understanding of Prognosis in Non-metastatic Prostate Cancer: A Randomised Comparative Study of Clinician Estimates Measured Against the PREDICT Prostate Prognostic Model

Kelly Leonard, United Kingdom
   

Improving Outpatient Clinical Care Efficiency for Urethral Stricture Patients Using the Home UFlow Meter™

MS Mariya Dragova, United Kingdom
   

New Nurse Innovated Procedure RN Position in Urology Practice

Rena Pinkasova, United States
1155-1205    

Study on the Related Factors of Vagal Reflex in Patients After Painless Transperineal Prostate Biopsy

Husheng Li, China
1205-1225    

Counselling Skills for Nurses

Kay Talbot, Australia
1225-1230    

Q&A

1230-1315    

Lunch Break & Viewing of ePosters

1315-1355    

Developing Roles of the Urology Nurse

David Heath, Australia
1355-1430    

Medical Tourism – Implications of Apps/Video/Telehealth. Are We Meeting Our Patient’s Needs?

Vashti Livingston, United States
Todd Manning, Australia
1430-1500    

Testicular Cancer - Are Young Men Hearing the Message?

Peter Albers, Germany
Kay Talbot, Australia
1500-1530    

What’s New in Prostate Cancer?

Peter Black, Canada
Arveen Kalapara, Australia
   

Meeting Close

Kay Talbot, Australia

0830-1130

INN-03: MRI Master Class: Based on the Cambridge Prostate MRI and Biopsy Course  

Room: Theta/Sigma/Delta
Chair: Christof Kastner, United Kingdom

Overview

The quality and advantages of prostate MRI have redefined diagnostic practice in recent years. A recent publication of the Hansen BJUI papers, PROMIS and PRECISION, strongly advocates the use of multi-parametric MRI (mpMRI) for lesion detection and biopsy avoidance in the diagnostic pathway.

This established international workshop has traditionally addressed the approach to learning this new diagnostic tool on workstations in a multidisciplinary fashion involving radiologists, urologists, and pathologists.

The original Cambridge course has been delivered annually since 2013 with unanimous applause as a combined MRI & biopsy course. Components have been used successfully for numerous 1-day courses and seminars at the ECR2017, 2018 and 2019, the FT2015, 2018 and 2019, the SIU 2017 and 2018, and each year since 2013 in Cambridge as the original 2-day course.

08:30-08:35
Welcome and Introduction of Cambridge Course & Philosophy

08:35-08:50
Introduction to Prostate Cancer Diagnostics and the Role of MRI

08:50-09:10
Prostate MRI and PI-RADS

09:10-09:55
MRI Case Analysis

09:55-10:10
Abnormal Prostate MRI - Pearls & Pitfalls of Reading and Reporting

10:10-10:25
To Biopsy or Not to Biopsy – Clinical Application of Prostate MRI

10:25-10:35
Continued Learning and Introduction to MRIpro

10:35-11:30
MRI Case Analysis

This session is supported by Philips. 

 

0900-1030

DEMO: Demo Session: Tips and Tricks in fURS  

Room: Lamda

Pre-registration is required for this session.

During this session, attendees will be able to:

  • Learn indications of each technique (PCNL and Retrograde Intra-renal Surgery: RIRS)
  • Learn instrumentation for each technique (disposable and reusable equipment)
  • Learn basics for manipulation of endoscopes and Laser applications
  • Learn principles of management of endourological complications

0900-1030

PL-02: Plenary 02    

Room: Ballroom II -III
Honorary Chairs: Reynaldo Gómez, Chile / Peter Hammerer, Germany
0900-0908    

SIU Best Video Award Presentation

Reynaldo Gómez, Chile
0908-0910    

SIU Academy Award for Outstanding Content Presentation

Honorary Chair: Peter Hammerer, Germany
0910-0925    

The European Association of Urology Lecture: Shock Wave Therapy for Erectile Dysfunction and Peyronie’s Disease: Where Are We Today?

Jens Sønksen, Denmark
0925-0940    

Pan African Urological Surgeons Association Lecture: Challenges in Urological Reconstruction in Sub-Saharan African

Alexander M.E. Nwofor, Nigeria
0940-1005    

Panel: Case-based Management of Upper Tract Urothelial Carcinoma

Moderator: Ashish M. Kamat, United States
Panelists
Peter Black, Canada
Marc Dall'Era, United States
Badrinath Konety, United States
Pilar Laguna, Türkiye
1005-1010    

Late-Breaking: IMvigor130: Efficacy and Safety of Atezolizumab With or Without Chemotherapy in Previously Untreated Metastatic Urothelial Carcinoma

Aristotelis Bamias, Greece
1010-1025    

Training the Next Generation of Urologists

Victor Nitti, United States
1

 

At the end of this lecture, participants will be able to:

  • Understand the changing landscape of how resident and medical student learn
  • Appreciate new interactive forms of teaching/learning
  • Incorporate practice-based learning into a residency curriculum
  • Discuss changes in surgical training and implementation of simulation
1025-1040    

Focal Therapy in Prostate Cancer

Yinghao Sun, China
1



0900-1030

INN: Resident Mentoring Session I  

Room: Aphrodite III
Moderator: Pradeep Rao, India

Advanced registration required. Limited spaces available.

   

Mentors

Mevlana Derya Balbay, Türkiye
Shin Egawa, Japan
Antonio Finelli, Canada
Margit Fisch, Germany
Michael Grasso, United States
Bradley Leibovich, United States
Seth Lerner, United States
Anthony Mundy, United Kingdom

1030-1100

Break in Exhibit Hall  

Room: To Be Determined

1100-1230

PP-01: Endourology Around the World  

Room: Ypsilon I-II-III
Co-Chairs: Jean de la Rosette, Türkiye / Anthony Chi-Fai Ng, Hong Kong

At the end of this session, attendees will be able to:

  • Provide an update on the latest development in medical therapy and shockwave therapy for urinary stones.
  • Provide tips and tricks for endoscopic surgery by lectures and also case discussion.
  • Discuss about the cost-saving approach in the application of endoscopic instruments.
1100-1112    

Tips and Tricks: Ultrasound-Guided Percutaneous Access

Ravindra Sabnis, India
1112-1124    

Ureteroscopy on a Budget: How to Make It Work

Giovanni Marchini, Brazil
1124-1136    

Medical Expulsive Therapy Is Dead

Matthew Bultitude, United Kingdom
1136-1148    

Management of Bladder Stones in the Endemic Population

Shingai Mutambirwa, South Africa
1148-1200    

Shockwave Lithotripsy: Trends and Innovation

Amy Krambeck, United States
1200-1230    

Case-Based Panel Discussion

Moderators
Jean de la Rosette, Türkiye
Anthony Chi-Fai Ng, Hong Kong

Panelists
Anastasios Anastasiadis, Greece
Jiang-Xing Li, China
Omer Levent Tuncay, Türkiye

1100-1230

JS-03: Joint SIU-GURS Symposium  

Room: Omikron
Chair: Kurt McCammon, United States

At the end of this session, attendees will be able to:

  • Describe treatment options for recurrent vesico urethral anastomotic stenosis.
  • Discuss treatment options for urethral stricture in SCI patients.
  • Discuss how to manage a patient with an eroded AUS and how to manage him going forward. 
1100-1130    

Case of Recurrent BN Contracture Post RRP and Radiotherapy

Moderator: Jaspreet S. Sandhu, United States
1100-1110    

Endoscopic Management: Is It Worthwhile?

1110-1120    

Primary Resection and Anastomoses: Is It for Experts Only? 

Ramon Virasoro, United States
1120-1130    

Diversion: The Sooner the Better 

Margit Fisch, Germany
1130-1150    

Stricture in Neuropathic Patient on CIC: 

Moderator: Sean P. Elliott, United States
1130-1140    

A Case for Urethroplasty 

1140-1150    

A Case Against Urethroplasty: SP Tube or Diversion Is the Answer 

Mélanie Aubé-Peterkin, Canada
1150-1230    

Erosion of AUS in a Radiated Patient 

Moderator: Gopal Badlani, United States
1150-1200    

Why Does It Happen and Initial Management 

Paul Rusilko, United States
1200-1210    

Reimplant of AUS: Tips and Tricks 

Allen Morey, United States
1210-1220    

Reimplant Is Futile; Consider Diversion

Francisco E. Martins, Portugal
1220-1230    

Discussion

1100-1230

INN: Resident Mentoring Session II  

Room: Aphrodite III

Advanced registration required. Limited spaces available.

   

Mentors

Stavros Gravas, Cyprus
Axel Heidenreich, Germany
Ashok Hemal, United States
Makarand Khochikar, India
Ajay Nehra, United States
Victor Nitti, United States
Athanasios (Thanos) Papatsoris, Greece
Arnulf Stenzl, Germany
Henry Woo, Australia

1100-1230

IC-06: Instructional Course 06: Screening and Markers in Prostate Cancer    

Room: Ypsilon IV-V
Chair: Laurence Klotz, Canada

 

1100-1120    

Prostate Cancer Screening 2019: Doing It Right

Laurence Klotz, Canada
1120-1135    

Use of Molecular Biomarkers in Screening

Derya Tilki, Germany
1135-1150    

Developments in Imaging Prior to Biopsy — Are Systematic Biopsies Still Required?

Laurence Klotz, Canada
1150-1205    

Use of Molecular Biomarkers in Localized Prostate Cancer Management

Derya Tilki, Germany
1205-1225    

Case Discussion

Laurence Klotz, Canada
Derya Tilki, Germany
1225-1230    

Questions & Answers

1100-1230

IC-07: Instructional Course 07: How to Start a Comprehensive Robotic Surgery Program  

Room: Athenaeum
Chair: Christian Bach, Germany

At the end of this session, attendees will know:

  • What are the requirements in terms of training, equipment, facilities and team building to successfully start a program.
  • How to perform a robotic radical prostatectomy – presented by a high volume surgeon.
  • How to perform RACX with focus on intracoporeal urinary diversion – presented by one of the early adopters.
  • How to use the robot for upper tract surgery including partial nephrectomy and pyeloplasty.
1100-1105    

Introduction and Welcome

Christian Bach, Germany
1105-1120    

How to Start a Robotic Surgical Program from Scratch

Christian Bach, Germany
1120-1140    

Robotic Radical Prostatectomy – How I Do It and How to Learn It

Jonathan Aning, United Kingdom
1140-1200    

Robotic Radical Cystectomy with Intracoporeal Urinary Diversion

Rakesh Heer, United Kingdom
1200-1220    

Robotic Upper Tract Surgery – Tips and Tricks

Christian Bach, Germany
1220-1230    

Questions and Discussion

Christian Bach, Germany

1200-1600

INN-02: SIU Innovators MRI-TRUS Fusion Hands-On Course  

Room: Theta/Sigma/Delta
Chair: Peter Black, Canada
   

Faculty

Marc Dall'Era, United States
Boris Hadaschik, Germany
Robert Reiter, United States

1230-1400

Break and Luncheon Symposium  

Room: To Be Determined

1400-1530

DEMO: Demo Session: Tips and Tricks in fURS  

Room: Lamda

Pre-registration is required for this session.

During this session, attendees will be able to:

  • Learn indications of each technique (PCNL and Retrograde Intra-renal Surgery: RIRS)
  • Learn instrumentation for each technique (disposable and reusable equipment)
  • Learn basics for manipulation of endoscopes and Laser applications
  • Learn principles of management of endourological complications

1400-1530

IS-02: Interactive Session 02— Male Voiding Dysfunction Including Sphincters  

Room: Omikron
Co-Chairs: Ajay Nehra, United States / Alan Wein, United States

At the end of this session, attendees will be able to:

  • Explain the diagnosis of underactive bladder affects the management strategy for BPH; how to make the diagnosis of detrusor underactivity.
  • Explain bladder neck dysfunction, how to suspect and diagnose it, what are management strategies.
  • Recall the array of operative procedures available for the surgical management of BPH and the  prostate factors that may make one option more or less attractive.
  • Outline the second and third line treatments for “refractory” overactive bladder and the circumstances that may make one more attractive than another for a particular clinical situation.

Methods: Case presentations with erudite discussant, including an evidence review; Power Point assist; Questions and Comments from the audience with comments from the panel.

1400-1415    

Update on UAB

Alan Wein, United States
1415-1430    

Severe Bladder Neck Dysfunction in Young(40ish) Man Concerned with Fertility and Ejaculate Preservation

Tufan Tarcan, Turkey
1430-1445    

Typical BPH with Symptoms and Significant Residual, High Pressure, Low Flow: Choice of Procedure - What Factors to Consider, What Procedure

Andrea Tubaro, Italy
1445-1500    

Refractory OAB, Sequence of Second Line Therapies

Panelists
Tufan Tarcan, Turkey
Andrea Tubaro, Italy
1500-1530    

Member Submitted Video(s) - TBC

1500-1515    

MIST

Ajay Nehra, United States

1400-1530

MV-03: Master Videos 03—New Techniques in BPH Surgery  

Room: Ballroom II -III
Co-Chairs: Stavros Gravas, Cyprus / Henry Woo, Australia

At the end of this session, attendees will be able to:

  • List the available new options for the surgical management of Benign Prostatic Obstruction (BPO).
  • Summarize the differences between the presented surgical therapies.
  • Explain the possible advantages and limitations of each surgical modality.
  • Select and recommend the appropriate treatment for the right patient.

Methods: Practical video demonstration of surgeries with sufficient time to pause/rewind; Discussion of the various available options for the same problem with the involvement of the audience.

1400-1410    

Convective Water Vapor Energy (WAVE) Ablation: Is It Different from TUNA-TUMT?

Claus Roehrborn, United States
1415-1425    

Image Guided Robotic Waterjet Ablation (Aquablation): Ready for Prime Time?

Peter Gilling, New Zealand
1430-1440    

Prostatic Urethral Lift (PUL): Are There Any Limits?

Peter Chin, Australia
1445-1455    

Green Light Enucleation: Do We Abandon Laser Ablation?

Kevin Zorn, Canada
1500-1530    

Member Submitted Videos

1500-1510    

Laparoscopic Simple Prostatectomy

Markos Karavitakis, Greece
1510-1520    

Urolift - Case and Demonstration

Peter Tsafrakidis, United Kingdom
1520-1530    

Convective Water Vapor Energy (WAVE) Ablation - Case and Demonstration

Peter Tsafrakidis, United Kingdom

1400-1530

MP-06: Moderated ePoster Session 06 - Penis/Testis/Urethra and Transplant  

Room: Ypsilon I-II-III
Moderator: Sia Daneshmand, United States

ePoster listing is available here.

1400-1530

MP-06: Moderated ePoster Session 07 - Minimally Invasive Surgery  

Room: Athenaeum
Moderators: Alivizatos Gerasimos, Greece / Homayoun Zargar, Australia

ePoster listing available here.

1400-1530

MVP-04: Moderated Video Session 04 - Stones/Transplant  

Room: Ypsilon IV-V

Click to view videos here.

1400-1530

IC-08: Instructional Course 08: Treatment Beyond Robot-Assisted PCa: Chart Possible Paths Toward a Sustainable Future (HIFU, Cryo,etc.)  

Room: Aphrodite III
Chair: Kevin Lu, Taiwan

At the end of this session, attendees will be able to:

  • Discuss and evaluate the current available clinical evidence for the high-intensity focused ultrasound (HIFU), cryotherapy and other emerging therapeutic modalities for prostate cancer.
  • Appraise current surveillance strategies after definitive treatment for prostate cancer, and discuss the complexities of various imaging and molecular testing modalities in clinical setting and their effects on therapeutic decisions, including opportunities and challenges with biopsy, rebiopsy, and liquid biopsy techniques.
  • Effectively determine individualized treatment plans for patients with prostate cancer using the latest agents in appropriate sequences or combinations in accordance with up-to-date evidence and expert recommendations throughout the disease continuum.
  • Refer appropriate patients with prostate cancer to ongoing clinical trials of assessing novel therapies alone and in combination throughout the disease continuum to aid in trial enrollment.
1400-1430    

Energy-Based Therapy for Localized Prostate Cancer: Evolution or Revolution?

Shu-Chi Wang, Taiwan
1430-1500    

Post-Treatment Surveillance: Beyond PSA, How Far Can We Reach?

Kevin Lu, Taiwan
1500-1530    

Align Your Practice into Rapidly Evolving Standard of Care Through Disease Continuum: Matching Treatment to Patients in an Ever-Changing Treatment Landscape for Advanced Prostate Cancer

Chen-Che Chen, Taiwan

1530-1545

Break in Exhibit Hall  

Room: To Be Determined

1545-1715

IC-09: Instructional Course 09: Management of Non-Muscle Invasive Bladder Cancer (NMIBC) - Are We Doing the Right Thing?  

Room: Aphrodite III
Chair: Makarand Khochikar, India

At the conclusion of this activity, participants will be able to:

  • Have a clarity on current strategies in the treatment of NMIBC, the most common yet not appropriately addressed cancer in urologic oncology.
1545-1550    

Introduction

Makarand Khochikar, India
1550-1605    

Optimizing the First TURBT - Technique, Do's and Dont's

Mark Soloway, United States
1605-1620    

Are We Over Indulging in Restaging TURBT

Ashish M. Kamat, United States
1620-1635    

Changing Paradigm in Intravesical Therapy for NMIBC

Badrinath Konety, United States
1635-1715    

Challenging Cases

Makarand Khochikar, India

1545-1715

IS-03: Interactive Session 03— Urolithiasis Management and Complications  

Room: Omikron
Co-Chairs: Athanasios (Thanos) Papatsoris, Greece / Dimitrios Staios, Greece

Nowadays, modern technology has shifted the treatment of urolithiasis to more minimally invasive techniques. Most progression has been demonstrated in retrograde intrarenal surgery with novel scopes and lasers.

The different treatment modalities as well as their complications will be discussed in this interactive session with expert stone surgeons.

At the conclusion of this activity, participants will be able to:

  • Identify the best management options for urolithiasis in relation to stone and patient parameters,
  • Compare the pros and cons of different treatment modalities,
  • Determine the optimal settings of lithotripsy devices (e.g. lasers),
  • Recommend ways to prevent and early diagnose complications of stone management,
  • Select the appropriate management of complications as well as relevant follow-up.
   

Panelists

Mariano Sebastian González, Argentina
Lukman Hakim, Indonesia
Wenqi Wu, China

1545-1715

MV-04: Master Videos 04— Laparoscopic Renal Surgery: New Techniques  

Room: Ballroom II -III
Co-Chairs: Edmund Chiong, Singapore / Bradley Leibovich, United States

At the end of this session, the learner will:

  • Gain exposure to various methods of access, use of adjuncts, and new techniques employed in laparoscopic renal surgery.
  • Appreciate the impact of technological and technical advances on the outcomes of laparoscopic renal surgery.
  • Learn and review evolving approaches to minimally invasive renal surgery.
1545-1610    

New Renorrhaphy Techniques for Partial Nephrectomy or Other Adjuncts Used in Laparaoscopic Renal Surgery

Jihad Kaouk, United States
1610-1635    

Surgery of Inferior Vena Cava Tumor Thrombus in Renal Cell Carcinoma: Peking University Third Hospital's Experience

Shudong Zhang, China
1635-1700    

Complex Robotic IVC Cases in Patients with RCC: From Extirpation to Caval Replacement

Gennady Bratslavsky, United States
1700-1715    

Discussion

1545-1715

MP-08: Moderated ePoster Session 08 - Reconstruction and Adrology  

Room: Athenaeum

To view list of ePosters, please click here.

1545-1715

MP-09: Moderated ePoster Session 09 - Stones and Trauma  

Room: VIP Lounge
Moderators: Pankaj Maheshwari, India / Konstantinos Ntoumas, Greece

ePoster listing available here.

1545-1715

MP-10: Moderated ePoster Session 10 - Kidney & Ureter, Adrenals  

Room: Ypsilon I-II-III
Moderator: Ioannis Gkialas, Greece

ePoster listing available here.

1545-1715

MVP-05: Moderated Video Session 05 - Oncology, Non-Prostate  

Room: Ypsilon IV-V
Moderators: Seth Lerner, United States / Mototsugu Oya, Japan

Click to view videos here.


Sunday, October 20

Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.

0800-0900

MC-07: Master Class 07— Muscle-Invasive Bladder Cancer: Surgical Aspects    

Room: Omikron
Co-Chair: Ashish M. Kamat, United States

At the conclusion of this activity participants will be able to:

  • Identify the recent advances in bladder cancer surgery including indications and approaches to radical cystectomy.
  • Recognize potential complications associated with bladder cancer surgery (including diversion) and develop skills and approaches to avoid such complications.
  •  Perform complex bladder cancer surgery (cystectomy and urinary diversion) with a comprehension of the work-up and surgical steps of the procedures.

Methods: The methods used to achieve the learning objectives include didactic presentation by experts in the field, video review of the techniques and approaches, and panel discussion with audience question/answer dedicated time.

0800-0802    

Introduction

Ashish M. Kamat, United States
0802-0815    

Robot Cystectomy: Tips, Tricks and Why I Prefer It

Juan Palou, Spain
0817-0830    

Open Cystectomy: Tips, Tricks and Why I Prefer It

Amlesh Seth, India
0832-0840    

Extent of Lymph Node dissection

Bernard Bochner, United States
0842-0850    

ERAS: The Great Leveller

Ashish M. Kamat, United States
0852-0858    

Audience Response and Discussion

0858-0900    

Summary and Conclusion

0800-0900

MC-08: Master Class 08— Chronic Pelvic Pain    

Room: Aphrodite III
Co-Chairs: John Heesakkers, The Netherlands / Philip Van Kerrebroeck, The Netherlands

By attending the master class the participants will:

  • Be able to compose a differential diagnosis of Chronic Pelvic pain according to the latest standards.
  • Gain insight in the existing pathophysiological models that try to explain IC/BPS.
  • Gain knowledge about the available tools for the treatment of IC/BPS being with or without cystoscopical visible pathological phenotypes. 

 

Methods: Lectures and presentations including videos, case examples, and discussion.

0800-0812    

Pathophysiology and Diagnostics

John Heesakkers, The Netherlands
0812-0824    

Treatment Options in Case of Visible Bladder Anomalies (Hunner’s Lesions)

Philip Van Kerrebroeck, The Netherlands
0824-0836    

Treatment Options without Visible Bladder Anomalies

Paulo Dinis Oliveira, Portugal
0836-0848    

New European Basic Research Developments in IC/BPS

Dick Janssen, The Netherlands
0848-0855    

Discussion

0855-0900    

Conclusion

John Heesakkers, The Netherlands
Philip Van Kerrebroeck, The Netherlands

0800-0900

MC-09: Master Class 09— Urological Complications of Renal Transplantation  

Room: Ypsilon IV-V
Co-Chairs: Rajesh Ahlawat, India / Arnaldo Figueiredo, Portugal

At the end of this session, attendees will be able to:

  • Prevent post renal transplant urological morbidities (Lymphoceles and ureteral strictures) and other complications.
  • Analyze if some of these be prevented if diagnosed pre-transplant (like neurogenic bladder and BOO).
  • Suspect a complication early and its diagnosis to reduce morbidity and graft losses.
  • Recall treatment strategies to manage a post transplant complication, and reduce treatment morbidity.
0800-0812    

Ureteral Strictures

Rajesh Ahlawat, India
0815-0827    

Lymphoceles

Arnaldo Figueiredo, Portugal
0830-0842    

Neurogenic Bladder and LUTS Post-transplant (Approach to Bladder Storage problems, BOO, Urethral Strictures)

0845-0857    

Lithiasis

Anant Kumar, India

0800-1000

IC-15: Instructional Course 15: Reconstrucción uretral para todos: De lo simple a lo complejo  

Room: Theta/Sigma/Delta
Chair: Reynaldo Gómez, Chile

This course will be taught in Spanish

At the conclusion of this activity, participants will be able to:

  • Identify the signature characteristics of the different segments of the male urethra 
  • Interpret the findings of imaging studies to differentiate healthy from diseased urethra
  • Describe the decision-making process to select the most appropriate surgical technique for each case
  • Understand potential complications of each technique and their implications
0800-0805    

Bienvenida

Reynaldo Gómez, Chile
0805-0835    

Primero conocer el alfabeto: Lo clínico

Felix Campos-Juanatey, Spain
0835-0905    

Luego construir los versos: Las técnicas

0905-0925    

Armando las estrofas: Videos Seleccionados

Felix Campos-Juanatey, Spain
0925-0950    

Finalmente el poema: Casos clínicos clásicos

Reynaldo Gómez, Chile
0950-1000    

Canto general: Preguntas y discusión

Felix Campos-Juanatey, Spain
Reynaldo Gómez, Chile

0900-1030

PL-03: Plenary 03    

Room: Ballroom II -III
Honorary Chairs: Jean de la Rosette, Türkiye / Sanjay Kulkarni, India
0900-0902    

SIU Academy Award Presentation for Outstanding Content

Honorary Chair: Jean de la Rosette, Türkiye
0903-0905    

Introduction to SIU-Albert Schweitzer Award Lecture

0905-0920    

SIU-Albert Schweitzer Award Lecture: Share Yourself, It Is Easy To Give

Gopal Badlani, United States
0920-0935    

Urological Association of Asia Lecture: From Innovation to Routine—Urological Laparoscopy and What is Beyond

Allen W. Chiu, Taiwan
0935-0950    

Confederacion Americana de Urologia Lecture: Is Multiparametric MRI the Way to go for Focal Therapy in Localized Prostate Cancer?

Arturo Mendoza-Valdes, Mexico
0950-1005    

How to Reduce Scientific Error (Clinical and Research)

Laurence Klotz, Canada
1005-1010    

Late-Breaking: Oncofid-P-B for the Treatment of BCG Unresponsive Carcinoma in situ (CIS) of the Bladder: Results of European Multicentre phase 1 Study at the End of 12 Consecutive Weeks Intensive Course

Massimo Lazzeri, Italy
1010-1025    

AI and Big Data

Ganesh Palapattu, United States
1

 

At the end of this lecture, participants will be able to:

  • Define artificial intelligence and big data
  • Recognize the value and future impact of artificial intelligence and big data in medicine and urology
  • Give examples of how artificial intelligence and big data may improve the practice of medicine and urology
1025-1030    

Discussion

1030-1100

Break  

Room: To Be Determined

1030-1230

SYMP-16: Hellenic Urological Association Symposium: Modern Trends in Urolithiasis Management  

Room: Ballroom II -III
Chair: Ioannis Gkialas, Greece
1030-1130    

PART I

Co-Chairs
Ioannis Gkialas, Greece
Andreas Skolarikos, Greece
1030-1045    

Metabolic Evaluation in Stone Disease: When and How

Charalampos Fragkoulis, Greece
1045-1100    

Targeting Techniques in PCN

Dimitrios Staios, Greece
1100-1115    

Serious Complications of PCNL

Stilianos Giannakopoulos, Greece
1115-1130    

Lithiasis in Specific Cases (i.e. Pregnancy, Horseshoe Kidney)

Panagiotis Kallidonis, Greece
1130-1230    

PART II

Co-Chairs
Athanasios (Thanos) Papatsoris, Greece
Iraklis Poulias, Greece
1130-1150    

Debate: SWL vs URS

1130-1140    

SWL

Athanasios Dellis, Greece
1140-1150    

URS

Markos Karavitakis, Greece
1150-1210    

Debate: Disposable vs Reusable Flexible URS

1150-1200    

Disposable

Charalampos Mamoulakis, Greece
1200-1210    

Reusable

Nikolaos Ferakis, Greece
1210-1230    

Debate: Lower Pole Stone: RIRS vs PCNL

1210-1220    

RIRS

Stavros Tyritzis, Greece
1220-1230    

PCNL

Ioannis Kartalas-Goumas, Italy

1100-1230

CONT-02: Controversies in Urology 02— High Risk and Oligometastatic Prostate Cancer  

Room: Aphrodite III
Co-Chair: John Davis, United States

At the end of this session, attendees will be able to:

  • Present novel imaging techniques in PET scanning that may change the staging of patients with potential metastatic disease.
  • Debate the patient benefits of salvage pelvic lymph node dissection.
  • Debate the patient benefits of systemic therapy for oligometastatic disease.
  • Update clinical research and current strategies for neoadjuvant therapy before surgery or radiation for high risk disease.
1100-1125    

Debate: Novel Imaging in “Early” Metastatic Disease—Precision or Confusion?

   

Precision

Boris Hadaschik, Germany
   

Confusion

Sudhir Rawal, India
   

Discussion

1130-1155    

Debate: Oligometastatic Lymph Node Positive Disease—Salvage PLND vs Systemic Therapy

   

Salvage PLND

Axel Heidenreich, Germany
   

Systemic Therapy

Eleni Efstathiou, Greece
   

Discussion

1200-1225    

Debate: High Risk Disease—Future Pathways of Neoadjuvant Therapy with Surgery vs XRT/ADT with Novel Systemic Therapy

   

Surgery

John Davis, United States
   

XRT/ADT with Novel Systemic Therapy

Axel Heidenreich, Germany
   

Discussion

1100-1230

PP-02: Recent and Important Observations in Urology  

Room: Ypsilon I-II-III
Co-Chairs: Nitin Kekre, India / James N'dow, United Kingdom

At the end of this session, attendees will be able to:

  • Identify which patient characteristics are best suited for Active Surveillance and focal therapy.
  • Better understand the place of practice changing trials such as STAMPEDE in daily clinical practice.
  • Learn whether there is anything new in bladder cancer and penile cancer management that could improve daily practice.
  • Receive an update on what’s new in minimally invasive treatments in male LUTS and to understand the importance of evaluation to ensure evidence-based care.
  • The presentations will use a case-based approach to highlight the most important recent scientific reports which would ensure relevance for both jobbing urologists and university academic surgeons.
1100-1112    

Diagnosis and Management of Low Risk Prostate Cancer

Laurence Klotz, Canada
1112-1124    

Contemporary Management of Penile Cancer

Arabind Panda, India
1124-1136    

Focal Therapy in Prostate Cancer Management - Myth or Reality

Jonathan Coleman, United States
1136-1148    

Bladder Cancer Clinical Studies that Have Impacted Clinical Practice in the Past 5 Years

Kilian M. Gust, Austria
1148-1200    

Is There a Place for Minimally Invasive Treatments in Male LUTS

Stavros Gravas, Cyprus
1200-1212    

Technical Innovation in Urology: Evaluation before Implementation

Dionysios Mitropoulos, Greece
1212-1224    

STAMPEDE Trial for the Jobbing Urologist

Noel Clarke, United Kingdom
1224-1230    

Discussion

1100-1230

JS-04: Joint SIU-SURS Symposium  

Room: Omikron
Chair: Jihad Kaouk, United States

At the end of this session, attendees will be able to:

  • State what's new in Surgical treatment of Prostate Cancer.
  • Recognize emerging procedures in robotic surgery.
  • Recall technical tips and tricks for current robotic procedures.
   

Oncologic and Robotic Innovations in Urology

1100-1105    

Welcome and Introduction of Program, Overview of SURS

Jihad Kaouk, United States
1105-1120    

Robotic Total Prostatectomy: A novel Technique for Low Risk Prostate Cancer

Ashok Hemal, United States
1120-1135    

Controversies in Intermediate Risk Prostate Cancer

John Davis, United States
1135-1150    

Radical Prostatectomy for the Oligo-Metastatic Prostate Cancer

Homayoun Zargar, Australia
1150-1200    

Questions & Answers

1205-1230    

Movie Session: Single Port Surgery Is Coming Back: New Systems and New Techniques

Moderators
Aly Abdel-Karim, Egypt
John Davis, United States
Ashok Hemal, United States
Andreas Skolarikos, Greece
Homayoun Zargar, Australia
1205-1215    

Robotic Perineal Prostatectomy Using XI Robotic System

Oktay Akça, Turkey
Selami Albayrak, Türkiye
1215-1223    

Robotic Perineal Prostatectomy Using New Generation SP Robot System

Jihad Kaouk, United States
1223-1230    

Robotic Single Port Cystectomy and Intracorporeal Urinary Diversion

Jihad Kaouk, United States

1100-1230

RF: Residents Forum: Moderated ePoster Session Part 1  

Room: VIP Lounge
Moderators: Maurice Garcia, United States / Charalampos Konstantinidis, Greece

Click here to view ePosters.

1100-1230

IC-10: Instructional Course 10: Bleeding Complications of PCNL – Prevention and Management  

Room: Athenaeum
Chair: Ravindra Sabnis, India

At the end of this session, attendees will be able to:

  • Understand the cause of bleeding.
  • Understand when, why & at which steps, bleeding occurs while doing PCNL.
  • Understand cause of post PCNL bleeding.
  • Understand how to manage bleeding once it occurs.
  • Understand what are the steps to be taken to prevent bleeding.
1100-1105    

Introduction & Objectives

Ravindra Sabnis, India
1105-1125    

Causes & Presentations of Bleeding During & After PCNL

Ravindra Sabnis, India
1125-1145    

Step by Step Management of Bleeding - Intraoperative & Postoperative PCNL

Ranan Dasgupta, United Kingdom
1145-1205    

Preventive Steps to Avoid Bleeding Complications in PCNL

S. K. Pal, India
1205-1230    

Case-Based Discussion

Moderator: Ravindra Sabnis, India
Ranan Dasgupta, United Kingdom
S. K. Pal, India

1100-1230

IC-11: Instructional Course 11: Urologic Endoscopy in Resource Restricted Environments    

Room: Ypsilon IV-V
Chair: Kymora Scotland, United States

At the end of this session, attendees will be able to:

  • Define the optimal or recommended use of instruments.
  • Compare the possible cost saving uses.
  • Define and recognize risk from cost saving uses.
  • Improve the cost saving measures.
1100-1105    

Introduction and Outline of Objectives; Discussion of Disposables

Kymora Scotland, United States
1105-1115    

The Case for Minimally Invasive Surgery

Cyril Kamadjou, Cameroon
1115-1130    

Endourology: Advice from the Egyptian Experience

Ehab Tawfiek, Egypt
   

Endourology: Advice from the Egyptian Experience II

Ehab Tawfiek, Egypt
1130-1155    

Tips and Tricks in Endourology

Mohammed Lezrek, Morocco
1155-1205    

The Sri Lankan Magic Box for Endourology Training

Srinath Chandrasekera, Sri Lanka
1205-1210    

Global Partnerships in Endourology: Medi Tech Trust Model

Graham Watson, United Kingdom
1210-1215    

Questions & Answers

1215-1230    

Live Demonstration/Hands-On Opportunity and Continued Question and Answer Session

Kymora Scotland, United States

1100-1230

IC-12: Instructional Course 12: Novel BPH Therapies – Review of Technologies and Practical Instruction (Laser EEP, UroLift, Rezum, Aquablation)  

Room: Theta/Sigma/Delta
Chair: Dean Elterman, Canada

At the end of this session, attendees will be able to:

  • Understand the mechanism of action and technique for each of the novel BPH therapies.
  • Select the best patients for each procedure type based upon patient and prostate characteristics.
  • Gain knowledge of the clinical data supporting the use of each modality.
  • Understand best-practice technique for each modality based upon the literature and expert opinion.
  • Gain an appreciation for the challenges encountered and troubleshooting for each technology.
  • Appreciate the “tips & tricks” provided by the experts for performing these novel BPH therapies.
1100-1105    

Introduction

Dean Elterman, Canada
1105-1120    

UroLift – Prostatic Urethral Lift

Dean Elterman, Canada
1120-1135    

Rezum – Water Vapor Therapy

Kevin Zorn, Canada
1135-1150    

Aquablation – Robotic Water-Jet Ablation

Enrique Rijo, Spain
1150-1205    

Endoscopic Enucleation of the Prostate

1205-1220    

Round-Table Case Discussion

Dean Elterman, Canada
Enrique Rijo, Spain
Kevin Zorn, Canada
1220-1230    

Questions & Answers

1100-1230

IC-13: Instructional Course 13: Genitourinary Cancer Survivorship: A Practical Master-Class  

Room: Lamda
Chair: Steven Brandes, United States

At the end of this session, attendees will be able to:

  • Introduce the concept and discuss the establishment of a Genitourinary Survivorship Program.
  • Discuss the management of urethral stricture and bladder neck contractures in the cancer survivor.
  • Discuss the evaluation and complex management of urinary fistula in the cancer survivor.
  • Discuss the evaluation of the devastated urinary outlet related to cancer treatment, the role of reconstruction of the outlet and when to abandon the outlet and proceed with supravesical diversion.
  • Describe the evaluation and management of stress incontinence in the cancer survivor.
  • Describe the current concepts in prosthetic urology and how implantation of urologic prosthetics differ in the cancer survivor.
1100-1105    

Cancer Survivorship Introduction

Steven Brandes, United States
1105-1120    

How to Develop a GU Cancer Survivorship Hospital Based Program

Drew Peterson, United States
1120-1135    

Recto-Urinary Fistula Management in the Cancer Survivor

Steven Brandes, United States
1135-1150    

Post Prostatectomy Bladder Neck Contractures: Fight or Flight?

Cooper Benson, United States
1150-1205    

Radiation Induced Urethral Strictures and the Cancer Survivor

Reynaldo Gómez, Chile
1205-1220    

Inter Symphyseal Urinary Fistula Management in the Cancer Survivor

Simon Bugeja, Malta
1220-1230    

Questions and Answers

1230-1400

Break and Luncheon Symposium  

Room: To Be Determined

1400-1530

MP-11: Moderated ePoster Session 11 - Bladder Cancer  

Room: Athenaeum
Moderator: Edmund Chiong, Singapore

ePoster listing is available here.

1400-1530

MVP-06: Moderated Video Sessions 06 - Adrenals/Pediatrics  

Room: Ypsilon IV-V
Moderator: Konstantinos Stravodimos, Greece

Click to view videos here.

1400-1600

MV-05: Master Videos 05— Radical Prostatectomy  

Room: Ypsilon I-II-III
Co-Chairs: Markus Graefen, Germany / Koon Ho Rha, South Korea

At the end of this session, attendees will be able to:

  • Define the landmark steps of robotic and conventional laparoscopic radical prostatectomy such as bladder neck dissection, nerve-sparing, apical dissection and vesico-urethral anastomosis. They have discussed the significant anatomical structures that should be identified during radical prostatectomy.
  • Describe different surgical approaches and variations in surgical techniques i.e. anterior and posterior reconstruction. Moreover, some difficulties during the radical prostatectomy such as a large median lobe and bladder neck reconstruction are discussed and respective surgical tips for solutions are given.

The participant will get practical advice in an interactive discussion amongst various surgeons and will be able to consider this information in their respective upcoming surgeries.

1400-1415    

Retzius Sparing Prostatectomy: Simplified/Standardized Yonsei Method

Koon Ho Rha, South Korea
1415-1430    

Nerve-Sparing Robotic Radical Prostatectomy: The Martini-Klinik Technique

Markus Graefen, Germany
1430-1445    

Robotic Total Prostatectomy: A New Technique for Low-Risk Prostate Cancer

Ashok Hemal, United States
1445-1500    

Laparoscopic Radical Prostatectomy: Knacks and Tricks

Shin Egawa, Japan
1500-1515    

Anatomic Nuances during RARP Bladder Neck Dissection: Tricks & Tips to Navigate Difficult Morphology and Optimize Continence

Kevin Zorn, Canada
1515-1530    

Nerve Sparing Release Planes - Anterior/Posterior Combined Approach

John Davis, United States

1400-1600

MV-06: Master Videos 06—Transgender Surgery and Phallic Reconstruction for the General Urologist    

Room: Omikron
Co-Chairs: Richard Santucci, United States / André van der Merwe, South Africa

At the end of this session, attendees will be able to:

  • Understand the anatomy critical to creating a phallus/vaginoplasty or transplant a penis.
  • Outline of the stepwise approach to performing the different surgeries in trans men.
  • Recall what the potential results should be: functionally, anatomically and cosmetically.
  • Explain what the complications should be and managing/preventing of them.
1400-1405    

SIU Academy Award Presentation for Outstanding Content

Co-Chair: Richard Santucci, United States
1400-1415    

Penile Transplant

André van der Merwe, South Africa
1420-1435    

Forearm Phalloplasty

Richard Santucci, United States
1440-1455    

What the Urologist Should Know About the Care of the Phalloplasty Patient: Strictures

Christopher Nim, United Kingdom
1500-1515    

Vaginoplasty

Maurice Garcia, United States
1520-1535    

Robotic Vaginectomy or Peritoneal Vaginoplasty (or both: “Robotic Assisted Gender Confirming Surgery”)

Lee Zhao, United States
1540-1555    

Penile Prosthesis in Phalloplasty Patients

Vladimir Kojovic, Serbia

1400-1530

RF: Residents Forum: Moderated ePoster Session Part 2  

Room: VIP Lounge
Moderators: Arturo Mendoza-Valdes, Mexico / Dionysios Mitropoulos, Greece

To view a list of ePosters, please click here.

1400-1530

IC-14: Instructional Course 14: Tips and Tricks in Managing Complications in Laparoscopic Surgery  

Room: Aphrodite III
Chair: Arvind Ganpule, India

At the conclusion of this activity, participants will be able to:

  • Identify the factors leading to pre, intra and post-operative complications in laparoscopic surgery
  • Diagnose intraoperative complications and plan salvage strategy
  • Recognise potential laparoscopic vascular complications.
  • Outline the risk reduction strategies in managing the laparoscopic vascular complications
1400-1410    

How Do I Manage a Life Threatening Bleed from a Major Vessel During a Lap Nephrectomy

Aly Abdel-Karim, Egypt
1410-1420    

Disasters During Laparoscopic Uro-oncology Minimally Invasive Procedures: How Do I Manage

Ashok Hemal, United States
1420-1430    

Disasters Are Around the Corner: How Can I Be Prepared for Them?

Syed Mohammed Ghouse, India
1430-1530    

Panel Discussion: Access, Dissection & Black Pearls

Moderator: Arvind Ganpule, India
Panelists
Aly Abdel-Karim, Egypt
Syed Mohammed Ghouse, India
Ashok Hemal, United States